en:
  disease:
    DIS001L: Diphtheria
    DIS002L: Tetanus
    DIS003L: Pertussis
    DIS004L: Poliomyelitis
    DIS005L: Haemophilus influenzae b
    DIS006L: Hepatitis B
    DIS008L: Measles
    DIS009L: Mumps
    DIS010L: Rubella
    DIS011L: Chickenpox
    DIS014L: Tuberculosis
    DIS015L: Influenza
    DIS016L: Hepatitis A
    DIS017L: Yellow fever
    DIS018L: Typhoid
    DIS025L: Pneumococcus
    DIS027L: Tick-borne encephalitis
    DIS028L: Japanese encephalitis
    DIS029L: Smallpox-Monkeypox
    DIS030L: Rabies
    DIS031L: Dengue fever
    DIS032L: Rotavirus
    DIS033L: Shingles
    DIS034L: Leptospirosis
    DIS036L: Cholera
    DIS038L: Papillomavirus
    DIS040L: Malaria
    DIS041L: Brucellosis
    DIS042L: Exanthematous typhus
    DIS043L: Meningococcal C
    DIS044L: Meningococcal A
    DIS045L: Meningococcal B
    DIS046L: Meningococcal W
    DIS047L: Meningococcal Y
    DIS048L: Méningocoque
    DIS050L: Avian influenza
    DIS051L: Anthrax
    DIS052L: Botulism
    DIS053L: Lyme disease
    DIS054L: Hepatitis E
    DIS055L: Ebola
    DIS056L: Chikungunya
    DIS057L: COVID-19
    DIS058L: Human Respiratory Syncytial Virus
    DIS059L: Plague
    DIS060L: Herpes
    DIS061L: Tularemia
    DIS062L: Argentine hemorrhagic fever
    DIS063L: Adenovirus
    DIS064L: Venezuelan equine encephalitis
    DIS065L: Q fever
    DIS066L: Hantavirus
    DIS067L: Leishmaniasis
    DIS068L: Human parainfluenza viruses
    DIS070L: Cytomegalovirus
    DIS071L: Hepatitis C
    DIS072L: HIV infection
    DIS073L: Melanoma
    DIS074L: Streptococcus pyogenes
    DIS075L: Rift Valley fever
    DIS076L: Urinary infection
    DIS077L: Enterovirus
    DIS078L: Leprosy
    DIS079L: Pseudomonas aeruginosa
    DIS080L: Meningococcal X
  vaccine:
    VAC0084C: Influenza A(H5N1) vaccine
    VAC0084L: H5N1 pre-pandemic influenza vaccine, unspecified
    VAC0088C: Diphtheria toxoid (standard dose), tetanus toxoid and inactivated polio
      (trivalent) pediatric vaccine
    VAC0088L: DTIPV vaccine, unspecified
    VAC0101C: Recombinant Hepatitis B vaccine, unspecified dose
    VAC0101L: Hepatitis B vaccine, recombinant, unspecified
    VAC0102C: Inactivated hepatitis A vaccine, pediatric or adult dose
    VAC0102L: Inactivated hepatitis A vaccine, unspecified
    VAC0110C: Seasonal influenza vaccine
    VAC0110L: Influenza vaccine, unspecified
    VAC0111C: Live attenuated yellow fever vaccine
    VAC0111L: Yellow fever vaccine, unspecified
    VAC0112C: Typhoid vaccine, unspecified
    VAC0112L: Typhoid vaccine, unspecified
    VAC0113C: Vaccine rubella, live attenuated
    VAC0113L: Rubella vaccine, live attenuated, unspecified
    VAC0114C: Live attenuated measles vaccine
    VAC0114L: Live attenuated measles vaccine, unspecified
    VAC0130C: Live attenuated measles, mumps and rubella vaccine
    VAC0130L: MMR vaccine, live attenuated, unspecified
    VAC0131C: Whole virion inactivated rabies vaccine
    VAC0131L: Rabies vaccine, unspecified
    VAC0132C: Tetanus toxoid vaccine
    VAC0132L: Tetanus vaccine, unspecified
    VAC0133C: Live attenuated smallpox vaccine
    VAC0133L: Smallpox vaccine, unspecified
    VAC0134C: Tuberculosis vaccine
    VAC0134L: BCG vaccine, unspecified
    VAC0135C: Polio vaccine, live or inactivated (unspecified)
    VAC0135L: Polio vaccine, unspecified
    VAC0136C: Diphtheria toxoid (standard dose), tetanus toxoid and pertussis (whole-cell
      inactivated) pediatric vaccine
    VAC0136L: DTwP - Diphtheria-Tetanus-Pertussis, unspecified
    VAC0137C: Diphtheria toxoid (standard dose) and tetanus toxoid pediatric vaccine
    VAC0137L: DT vaccine, unspecified
    VAC0138C: Diphtheria toxoid (unspecified dose), tetanus toxoid, pertussis (whole-cell
      inactivated or acellular, unspecified dose) and inactivated polio (trivalent)
      vaccine
    VAC0138L: Diphtheria-Tetanus-Pertussis-Polio vaccine, unspecified
    VAC0143C: Haemophilus influenzae type b conjugate vaccine
    VAC0143L: Haemophilus influenzae B (or Hib) vaccine, unspecified
    VAC0144C: Cholera vaccine, unspecified
    VAC0144L: Cholera vaccine, unspecified
    VAC0145C: Tick-borne encephalitis vaccine, whole-virus inactivated, strain unspecified
    VAC0145L: Tick-borne encephalitis vaccine, unspecified
    VAC0146C: Live attenuated Japanese encephalitis vaccine, 14-14-2 strain
    VAC0146L: Live attenuated Japanese Encephalitis vaccine 14-14-2 strain, unspecified
    VAC0147C: Pandemic influenza A(H1N1)pdm09 vaccine, inactivated
    VAC0147L: Influenza A(H1N1)2009 vaccine, unspecified
    VAC0148C: Inactivated whole-cell leptospirosis vaccine
    VAC0148L: Leptospirosis vaccine, unspecified
    VAC0149C: Meningococcal vaccine, serogroup B (outer membrane vesicle protein B:14:P1.7,16)
    VAC0149L: Meningococcal B:14:P1.7,16 vaccine, unspecified
    VAC0150C: Meningococcal polysaccharide conjugate vaccine, serogroup C
    VAC0150L: Meningococcal conjugate vaccine C, unspecified
    VAC0151C: Unconjugated meningococcal polysaccharide vaccine, serogroups A and
      C
    VAC0151L: Meningococcal A + C vaccine, unspecified
    VAC0152C: Unconjugated meningococcal polysaccharide vaccine, serogroups A, C,
      W and Y
    VAC0152L: Unconjugated meningococcal vaccine ACWY, unspecified
    VAC0153C: Live attenuated mumps vaccine
    VAC0153L: Mumps vaccine, unspecified
    VAC0154C: Malaria vaccine (used in clinical trials)
    VAC0154L: Malaria vaccine, unspecified
    VAC0155C: Dengue vaccine, unspecified
    VAC0155L: Dengue vaccine, unspecified
    VAC0156C: Human Papillomavirus vaccine, unspecified
    VAC0156L: HPV Vaccine
    VAC0157C: Pneumococcal conjugate or non conjugate polysaccharide vaccine, number
      of serotypes unspecified
    VAC0157L: Pneumococcal vaccine, unspecified
    VAC0158C: Rotavirus vaccine
    VAC0158L: Rotavirus vaccine, unspecified
    VAC0159C: Live attenuated chickenpox vaccine
    VAC0159L: Chickenpox vaccine, unspecified
    VAC0160C: Live attenuated shingles vaccine
    VAC0160L: Live attenuated shingles vaccine, unspecified
    VAC0162C: Brucellosis vaccine
    VAC0162L: Brucellosis vaccine, unspecified
    VAC0163C: Pertussis (whole-cell inactivated) vaccine
    VAC0163L: Whole-cell inactivated pertussis vaccine, unspecified
    VAC0270C: Inactivated polio (trivalent) vaccine
    VAC0270L: Inactivated Polio vaccine, unspecified
    VAC0320C: Polio vaccine (live attenuated, trivalent) against polioviruses 1, 2
      and 3, oral
    VAC0320L: OPV 1-2-3, unspecified
    VAC0324C: Pneumococcal polysaccharide conjugate vaccine, 7-valent, serotypes 4,
      6B, 9V, 14, 18C, 19F and 23F
    VAC0324L: Pneumococcal conjugate vaccine, 7 valent, unspecified
    VAC0339C: Unconjugated pneumococcal polysaccharide vaccine, 23-valent, serotypes
      1, 2, 3, 4, 5, 6B, 7F, 8, 9N, 9V, 10A, 11A, 12F, 14, 15B, 17F, 18C, 19A, 19F,
      20, 22F, 23F and 33F
    VAC0339L: Pneumococcal polysaccharide vaccine 23-valent, unspecified
    VAC0344C: Haemophilus influenzae type b conjugate vaccine composed of PRP (polyribosylribitol
      phosphate) conjugated with OMP (Neisseria meningitidis outer-membrane protein)
    VAC0344L: PRP-OMP Hib vaccine, unspecified
    VAC0345C: Haemophilus influenzae type b conjugate vaccine composed of PRP (polyribosylribitol
      phosphate) conjugated to tetanus toxoid
    VAC0345L: Hib PRP-T conjugated vaccine, unspecified
    VAC0358C: Rabies immunoglobulin, human origin
    VAC0358L: Rabies immunoglobulin human origin, unspecified
    VAC0380C: Tetanus toxoid and inactivated polio (trivalent) vaccine
    VAC0380L: T.Polio, unspecified
    VAC0382C: Diphtheria toxoid (unspecified dose) and tetanus toxoid vaccine
    VAC0382L: Tetanus diphtheria vaccine, unspecified
    VAC0424C: Live attenuated typhoid vaccine, strain Ty21a, oral
    VAC0424L: Live attenuated oral typhoid vaccine, unspecified
    VAC0497C: Anti-tetanus immunoglobulin
    VAC0497L: Tetanus immunoglobulin, unspecified
    VAC0502C: Rabies immunoglobulin, human or equine origin
    VAC0502L: Rabies immunoglobulin, unspecified
    VAC0503C: Rabies immunoglobulin, equine origin
    VAC0503L: Rabies immunoglobulin equine origin, unspecified
    VAC0506C: Diphtheria toxoid (standard dose), tetanus toxoid, pertussis (multicomponent
      acellular, standard dose), Haemophilus influenzae type b (conjugated, unspecified)
      and inactivated polio (trivalent) pediatric vaccine
    VAC0506L: Pentavalent DTaPHibIPV vaccine, unspecified
    VAC0512C: Vaccine against epidemic typhus (epidemic lice typhus)
    VAC0512L: Typhus vaccine, unspecified
    VAC0549C: Diphtheria toxoid (low dose), tetanus toxoid and inactivated polio (trivalent)
      vaccine
    VAC0549L: dTIPV - Diphtheria-Tetanus-Polio, low dose, unspecified
    VAC0550C: Live attenuated measles and rubella vaccine
    VAC0550L: Measles-Rubella vaccine, unspecified
    VAC0551C: Diphtheria toxoid (standard dose), tetanus toxoid, pertussis (multicomponent
      acellular, standard dose) and inactivated polio (trivalent) pediatric vaccine
    VAC0551L: DTaPIPV vaccine, standard dose, unspecified
    VAC0552C: Diphtheria toxoid (standard dose), tetanus toxoid, pertussis (multicomponent
      acellular, standard dose), Haemophilus influenzae type b (conjugated, unspecified),
      inactivated polio (trivalent) and hepatitis B (recombinant) pediatric vaccine
    VAC0552L: Hexavalent vaccine DTPCaHibHepB - Diphtheria-Tetanus-Polio-Acellular
      Pertussis-Hib-HepB, unspecified
    VAC0553C: Diphtheria toxoid (standard dose), tetanus toxoid, pertussis (whole-cell
      inactivated), Haemophilus influenzae type b (conjugated, unspecified) and inactivated
      polio (trivalent) pediatric vaccine
    VAC0553L: Pentavalent DTwPHibIPV vaccine, unspecified
    VAC0585C: Diphtheria toxoid (low dose), tetanus toxoid, pertussis (multicomponent
      acellular, 5 components, low dose) and inactivated polio (trivalent) vaccine,
      adsorbed
    VAC0585L: TdapIPV - Diphtheria-Tetanus-Pertussis-Polio vaccine, low dose, unspecified
    VAC0596C: Diphtheria toxoid (standard dose), tetanus toxoid and pertussis (multicomponent
      acellular, standard dose), Haemophilus influenzae type b (conjugated, unspecified)
      and hepatitis B (recombinant) pediatric vaccine
    VAC0596L: DTaPHibHepB pentavalent vaccine, unspecified
    VAC0598C: Diphtheria toxoid (standard dose), tetanus toxoid, pertussis (whole-cell
      inactivated), Haemophilus influenzae type b (conjugated, unspecified) and hepatitis
      B (recombinant) pediatric vaccine
    VAC0598L: DTwPHibHepB pentavalent vaccine, unspecified
    VAC0599C: Diphtheria toxoid (standard dose), tetanus toxoid and pertussis (multicomponent
      acellular, unspecified dose), Haemophilus influenzae type b (conjugated, unspecified)
      and hepatitis B (recombinant) pediatric vaccine
    VAC0599L: DTPerHibHepB pentavalent vaccine, unspecified
    VAC0600C: Polio vaccine (live attenuated, bivalent) against poliovirus types 1
      and 3, oral
    VAC0600L: OPV bivalent 1-3, unspecified
    VAC0601C: Diphtheria toxoid (standard dose), tetanus toxoid and pertussis (whole-cell
      inactivated or acellular, unspecified dose) pediatric vaccine
    VAC0601L: DPT Diphtheria-Pertussis-Tetanus vaccine, unspecified
    VAC0602C: Diphtheria toxoid (standard dose), tetanus toxoid and pertussis (multicomponent
      acellular, standard dose) pediatric vaccine
    VAC0602L: DTaP - Diphtheria-Tetanus-Pertussis vaccine, standard dose, unspecified
    VAC0610C: Diphtheria toxoid (low dose), tetanus toxoid and pertussis (multicomponent
      acellular, low dose) vaccine
    VAC0610L: Tdap - Diphtheria-Tetanus-Pertussis vaccine, low dose, unspecified
    VAC0623C: Live attenuated measles and mumps vaccine
    VAC0623L: Measles-mumps vaccine, unspecified
    VAC0643C: Quadrivalent meningococcal polysaccharide conjugate vaccine, serogroups
      A, C, W and Y
    VAC0643L: Meningococcal ACWY conjugate vaccine, unspecified
    VAC0648C: COVID-19 vaccine
    VAC0648L: COVID-19 vaccine, unspecified
    VAC0653C: Combined hepatitis A and B vaccine, pediatric dose
    VAC0653L: Hepatitis A + Hepatitis B vaccine Child, unspecified
    VAC0654C: Combined hepatitis A and B vaccine, adult dose
    VAC0654L: Hepatitis A + Hepatitis B vaccine Adult, unspecified
    VAC0655C: Diphtheria toxoid (unspecified dose)
    VAC0655L: Diphtheria vaccine, unspecified
    VAC0711C: Polysaccharide typhoid conjugate vaccine
    VAC0711L: Typhoid conjugate vaccine, unspecified
    VAC0712C: Combined typhoid and hepatitis A vaccine
    VAC0712L: Typhoid-hepatitis A vaccine, unspecified
    VAC0713C: Polysaccharide typhoid vaccine (Vi capsular antigen)
    VAC0713L: Typhoid polysaccharide vaccine, unspecified
    VAC0775C: Diphtheria toxoid (standard dose), tetanus toxoid, pertussis (whole-cell
      inactivated) and Haemophilus influenzae type b (conjugated, unspecified) pediatric
      vaccine
    VAC0775L: DTwPHib, unspecified
    VAC0787C: Diphtheria toxoid (unspecified dose), tetanus toxoid and rubella (live
      attenuated) vaccine
    VAC0787L: Diphtheria-Tetanus-Rubella, unspecified
    VAC0788C: Haemophilus influenzae type b (conjugated, unspecified) and inactivated
      polio (trivalent) vaccine
    VAC0788L: Hib-IPV, unspecified
    VAC0790C: Diphtheria toxoid (unspecified dose), tetanus toxoid and hepatitis B
      (recombinant) vaccine
    VAC0790L: Diphtheria-Tetanus-Hepatitis B vaccine, unspecified
    VAC0791C: Diphtheria toxoid (standard dose), tetanus toxoid, pertussis (whole
      or acellular, unspecified dose), inactivated polio (whole, trivalent), Haemophilus
      influenzae type b (conjugate, unspecified) and hepatitis B (recombinant) pediatric
      vaccine
    VAC0791L: Hexavalent vaccine DTPerHibPHepB - Diphtheria-Tetanus-Pertussis-Polio-Hib-Hepatitis
      B vaccine, unspecified
    VAC0792C: Diphtheria toxoid (unspecified dose), tetanus toxoid, pertussis (whole-cell
      inactivated or acellular, unspecified dose), inactivated polio (trivalent) and
      hepatitis B (recombinant) vaccine
    VAC0792L: Diphtheria-Tetanus-Pertussis-Polio-Hepatitis B pentavalent vaccine,
      unspecified
    VAC0794C: Tetanus toxoid vaccine combined with anti-tetanus immunoglobulin
    VAC0794L: T-igT, unspecified
    VAC0795C: Pertussis (acellular, unspecified dose) vaccine
    VAC0795L: Acellular pertussis vaccine, unspecified
    VAC0796C: Pertussis vaccine (acellular or whole-cell inactivated)
    VAC0796L: Pertussis vaccine, unspecified
    VAC0797C: Diphtheria toxoid (unspecified dose), tetanus toxoid and pertussis (acellular,
      unspecified dose) vaccine
    VAC0797L: Diph-T-aP/ap, unspecified
    VAC0798C: Haemophilus influenzae type b and meningococcal conjugate vaccine, serogroup
      C
    VAC0798L: Hib-MeningoC vaccine, unspecified
    VAC0799C: Diphtheria toxoid (standard dose), tetanus toxoid and Haemophilus influenzae
      type b (conjugated unspecified) pediatric vaccine
    VAC0799L: DT-Hib vaccine, unspecified
    VAC0800C: Diphtheria toxoid (standard dose), tetanus toxoid, pertussis (acellular
      standard dose or whole-inactivated) and Haemophilus influenzae type b (conjugated,
      unspecified) pediatric vaccine
    VAC0800L: Diphtheria-tetanus-pertussis-Hib vaccine, unspecified
    VAC0801C: Haemophilus influenzae type b and hepatitis B vaccine
    VAC0801L: HepB-Hib, unspecified
    VAC0802C: Polio vaccine (live attenuated, monovalent), oral
    VAC0802L: Monovalent oral polio vaccine - type unknown, unspecified
    VAC0804C: Anthrax vaccine
    VAC0804L: Anthrax vaccine, unspecified
    VAC0805C: Inactivated whole-cell cholera vaccine for injection
    VAC0805L: Whole-cell inactivated cholera vaccine, unspecified
    VAC0806C: Live attenuated cholera vaccine
    VAC0806L: Live attenuated cholera vaccine, unspecified
    VAC0807C: Inactivated whole-cell cholera vaccine for injection combined with inactivated
      whole-cell typhoid vaccine
    VAC0807L: Cholera-Typhoid inactivated vaccine, unspecified
    VAC0808C: Haemophilus influenzae type b and meningococcal conjugate vaccine, serogroups
      C and Y
    VAC0808L: Hib-MenCY, unspecified
    VAC0809C: Meningococcal monovalent vaccine, conjugate or unconjugated polysaccharide
    VAC0809L: Meningococcal monovalent polysaccharide vaccine, unspecified
    VAC0810C: Meningococcal polyvalent unconjugated polysaccharide vaccine
    VAC0810L: Meningococcal polyvalent polysaccharide vaccine, unspecified
    VAC0811C: Meningococcal vaccine, serogroup B, type of vaccine unspecified
    VAC0811L: Meningococcal B vaccine, unspecified
    VAC0812C: Plague (whole-cell inactivated) vaccine
    VAC0812L: Inactivated whole plague vaccine, unspecified
    VAC0813C: Unconjugated pneumococcal polysaccharide vaccine, serotypes unspecified
    VAC0813L: Pneumococcal unconjugated polysaccharide vaccine, unspecified
    VAC0814C: Pneumococcal polysaccharide conjugate vaccine, number of serotypes unspecified
    VAC0814L: Pneumococcal conjugate vaccine, serotypes unspecified
    VAC0815C: Haemophilus influenzae type b and pneumococcal conjugate vaccine , unspecified
    VAC0815L: Pneumo-Hib, unspecified
    VAC0817C: Whole-cell inactivated typhoid vaccine
    VAC0817L: Inactivated Typhoid vaccine, unspecified
    VAC0818C: Typhoid and paratyphoid A and B vaccine, whole-cell inactivated
    VAC0818L: Typhoid-Paratyphoid vaccine, unspecified
    VAC0819C: Whole virion inactivated japanese encephalitis vaccine
    VAC0819L: Inactivated Japanese Encephalitis vaccine, unspecified
    VAC0820C: Whole virion inactivated seasonal influenza vaccine
    VAC0820L: Inactivated whole influenza vaccine, unspecified
    VAC0821C: Inactivated seasonal influenza vaccine
    VAC0821L: Inactivated influenza vaccine, split or subunit, unspecified
    VAC0822C: Seasonal influenza vaccine, live attenuated
    VAC0822L: Influenza vaccine, live attenuated, unspecified
    VAC0823C: Virus-Like Particle (VLP) seasonal influenza vaccine
    VAC0823L: VLP influenza vaccine, unspecified
    VAC0824C: Inactivated hepatitis A vaccine, virosome, pediatric or adult
    VAC0824L: Hepatitis A virosome vaccine, unspecified
    VAC0825C: Combined hepatitis A and B vaccine
    VAC0825L: Combined hepatitis A and hepatitis B vaccine, unspecified
    VAC0827C: Live attenuated measles, mumps, rubella and chickenpox vaccine
    VAC0827L: MMRV - Measles-Mumps-Rubella-Varicella vaccine, unspecified
    VAC0828C: Live attenuated pentavalent rotavirus vaccine, oral
    VAC0828L: Rotavirus pentavalent vaccine, unspecified
    VAC0829C: Live attenuated rubella and mumps vaccine
    VAC0829L: Rubella-Mumps vaccine, unspecified
    VAC0830C: Subunit shingles vaccine (currently corresponds to glycoprotein E)
    VAC0830L: Subunit shingles vaccine, unspecified
    VAC0831C: Ebola virus vaccine
    VAC0831L: Ebola vaccine, unspecified
    VAC0832C: Inactivated herpes simplex vaccine
    VAC0832L: Herpes Simplex vaccine, unspecified
    VAC0839C: Whole-cell inactivated brucellosis vaccine
    VAC0839L: Inactivated whole-cell brucella vaccine, unspecified
    VAC0849C: Tularemia vaccine
    VAC0849L: Tularemia vaccine, unspecified
    VAC0852C: Polio vaccine (live attenuated, monovalent) against polioviruses type
      2, oral
    VAC0852L: mOPV2 Sabin monovalent oral polio vaccine type 2, unspecified
    VAC0853C: Polio vaccine (live attenuated, monovalent) against poliovirus type
      1, oral
    VAC0853L: mOPV1 Sabin monovalent oral polio vaccine type 1, unspecified
    VAC0854C: Polio vaccine (live attenuated, monovalent) against poliovirus types
      3, oral
    VAC0854L: mOPV3 Sabin monovalent oral polio vaccine type 3, unspecified
    VAC0855C: Diphtheria toxoid (unspecified dose), tetanus toxoid and inactivated
      polio (trivalent) vaccine, adsorbed
    VAC0855L: Diphtheria-Tetanus-Polio vaccine, unspecified
    VAC0856C: Diphtheria toxoid (standard dose), tetanus toxoid and pertussis (multicomponent
      acellular, standard dose) and Haemophilus influenzae type b (conjugated, unspecified)
      pediatric vaccine
    VAC0856L: DTaPHib vaccine, unspecified
    VAC0857C: Diphtheria toxoid (standard dose), tetanus toxoid, pertussis (acellular
      standard dose or whole-inactivated) and hepatitis B (recombinant) pediatric
      vaccine
    VAC0857L: Diphtheria-Tetanus-Pertussis-Hepatitis B vaccine, unspecified
    VAC0858C: Human Papillomavirus vaccine, bivalent (types 16 and 18), recombinant
    VAC0858L: HPV vaccine bivalent, unspecified
    VAC0859C: Human Papillomavirus vaccine, quadrivalent (types 6, 11, 16, and 18),
      recombinant
    VAC0859L: HPV vaccine quadrivalent, unspecified
    VAC0860C: Human Papillomavirus vaccine, nonavalent (types 6, 11, 16, 18, 31, 33,
      45, 52, and 58), recombinant
    VAC0860L: HPV vaccine nonavalent, unspecified
    VAC0861C: Meningococcal vaccine, serogroup B (multicomponent - multiple proteins)
    VAC0861L: Multicomponent meningococcal B vaccine, unspecified
    VAC0862C: Measles immunoglobulin
    VAC0862L: Measles immunoglobulin, unspecified
    VAC0863C: Hepatitis B immunoglobulin
    VAC0863L: Hepatitis B immunoglobulin, unspecified
    VAC0864C: Varicella-Zoster immunoglobulin
    VAC0864L: Varicella-Zoster immunoglobulin, unspecified
    VAC0865C: Unconjugated meningococcal polysaccharide vaccine, serogroup A
    VAC0865L: Polysaccharide meningococcal A vaccine, unspecified
    VAC0866C: Meningococcal polysaccharide conjugate vaccine, serogroup A
    VAC0866L: Meningococcal conjugate vaccine A, unspecified
    VAC0867C: Diphtheria antitoxin
    VAC0867L: Diphtheria antitoxin, unspecified
    VAC0880C: Diphtheria toxoid (standard dose), tetanus toxoid, pertussis (unspecified),
      conjugate Haemophilus influenzae type b (conjugated, unspecified) and inactivated
      polio (trivalent) pediatric vaccine, adsorbed
    VAC0880L: Pentavalent Diphtheria-Tetanus-Pertussis-Hib-Polio (DTPerHibIPV) vaccine,
      unspecified
    VAC0881C: Live attenuated Japanese encephalitis vaccine, strain and production
      platform not specified
    VAC0881L: Live attenuated Japanese Encephalitis vaccine, unspecified
    VAC0894C: Adenovirus vaccine, unspecified type
    VAC0894L: Adenovirus vaccine, unspecified
    VAC0895C: Venezuelan equine encephalitis vaccine
    VAC0895L: Venezuelan Equine Encephalitis Vaccine, Unspecified
    VAC0896C: Q fever vaccine
    VAC0896L: Q fever vaccine, unspecified
    VAC0897C: Hantavirus vaccine
    VAC0897L: Hantavirus vaccine, unspecified
    VAC0898C: Leishmaniasis vaccine
    VAC0898L: Leishmaniasis vaccine, unspecified
    VAC0899C: Human Parainfluenza Virus Vaccine
    VAC0899L: Human Parainfluenza Virus Vaccine, unspecified
    VAC0902C: Whole virion inactivated rabies vaccine, prepared from goat or sheep
      brain tissue infected with rabies virus, contains myelin
    VAC0902L: Rabies vaccine Semple type, unspecified
    VAC0903C: Whole virion inactivated rabies vaccine, prepared from suckling mouse
      brain tissue infected with rabies virus, decreased myelin content
    VAC0903L: Rabies vaccine Fuenzalida type, unspecified
    VAC0904C: Whole virion inactivated rabies vaccine, purified duck embryo vaccine
      (PDEV), inactivated with ß-propiolactone
    VAC0904L: Rabies duck embryo vaccine, unspecified
    VAC0905C: Whole virion rabies inactivated vaccine, cell culture-based, primary
      hamster kidney cell vaccine (PHKCV), Beijing strain, inactivated with formalin
    VAC0905L: Rabies vaccine PHKCV, unspecified
    VAC0906C: Shingles vaccine
    VAC0906L: Shingles vaccine, unspecified
    VAC0907C: Adenovirus type 4 vaccine
    VAC0907L: Vaccine against adenovirus type 4, unspecified
    VAC0908C: Adenovirus type 7 vaccine
    VAC0908L: Vaccine against adenovirus type 7, unspecified
    VAC0909C: Antitoxin against botulism
    VAC0909L: Botulinum antitoxin
    VAC0910C: Inactivated hepatitis A vaccine, adult dose
    VAC0910L: Inactivated hepatitis A vaccine, adult dose, unspecified
    VAC0911C: Whole virion inactivated hepatitis A vaccine, monovalent, pediatric
      dose
    VAC0911L: Hepatitis A whole inactivated vaccine, monovalent, pediatric dose, unspecified
    VAC0912C: Whole virion Inactivated hepatitis A vaccine, pediatric dose, formulation
      not specified (monovalent or bivalent with hepatitis B)
    VAC0912L: Hepatitis A vaccine, pediatric dose, unspecified
    VAC0914C: Hepatitis B recombinant vaccine, monovalent, pediatric dose
    VAC0914L: Hepatitis B vaccine, monovalent, pediatric dose, unspecified
    VAC0915C: Recombinant hepatitis B vaccine, monovalent, adult dose
    VAC0915L: Hepatitis B vaccine, monovalent, adult dose, unspecified
    VAC0916C: Recombinant hepatitis B vaccine, monovalent, dialysis patient dosage
    VAC0916L: Hepatitis B vaccine, monovalent, dialysis patient dosage, unspecified
    VAC0917C: Recombinant Hepatitis E Peptide vaccine
    VAC0917L: Hepatitis E vaccine, unspecified
    VAC0918C: Hemophilus influenzae type b conjugate vaccine composed of PRP (polyribosylribitol
      phosphate) conjugated to diphtheria toxoid
    VAC0918L: PRP-D Hib vaccine, unspecified
    VAC0919C: Haemophilus influenzae type b vaccine, capsular oligosides (polyribosylribitol
      phosphate, PRP) conjugated to mutant diphtheria toxin CRM197
    VAC0919L: Hib hbOC vaccine, unspecified
    VAC0920C: Diphtheria toxoid (reduced dose) and tetanus toxoid vaccine
    VAC0920L: Diphtheria-tetanus Td vaccine, unspecified
    VAC0921C: Japanese encephalitis vaccine
    VAC0921L: Japanese encephalitis vaccine, unspecified
    VAC0922C: Adenovirus type 7 and 4 vaccine
    VAC0922L: Live attenuated adenovirus vaccine, type 4 and type 7, oral
    VAC0923C: Monoclonal antibody against RSV
    VAC0923L: Respiratory Syncytial Virus monoclonal antibody, unspecified
    VAC0925C: Trivalent inactivated seasonal influenza vaccine, split or subunit,
      standard dose
    VAC0925L: Trivalent inactivated influenza vaccine, unspecified
    VAC0927C: COVID-19 mRNA vaccine, pediatric dose
    VAC0927L: COVID-19 mRNA vaccine, paediatric dose, unspecified
    VAC0928C: Live attenuated hepatitis A vaccine
    VAC0928L: Live attenuated Hepatitis A vaccine, unspecified
    VAC0929C: Quadrivalent inactivated seasonal influenza vaccine, pediatric dose
    VAC0929L: Influenza quadrivalent inactivated vaccine, pediatric dose, unspecified
    VAC0932C: Quadrivalent recombinant seasonal influenza vaccine
    VAC0932L: Quadrivalent recombinant influenza vaccine, unspecified
    VAC0937C: Botulism vaccine
    VAC0937L: Botulism vaccine, unspecified
    VAC0938C: Quadrivalent inactivated seasonal influenza vaccine, split virion or
      surface antigen vaccine
    VAC0938L: Quadrivalent influenza vaccine, unspecified
    VAC0941C: Anthrax immunoglobuline
    VAC0941L: Immunoglobulin against anthrax, unspecified
    VAC0942C: Whole virion inactivated rabies vaccine, cultured in chicken embryo
      cells (CEEC), inactivated with ß-propiolactone
    VAC0942L: Chicken embryo rabies vaccine, unspecified
    VAC0943C: Whole virion inactivated rabies vaccine, prepared in human diploid cell
      culture (HDCV) MRC-5, inactivated with ß-propiolactone
    VAC0943L: Rabies vaccine diploid cells, unspecified
    VAC0944C: Oral Inactivated whole-cell cholera vaccine
    VAC0944L: Inactivated whole virion oral cholera vaccine, unspecified
    VAC0945C: Meningococcal vaccine, unspecified serogroup
    VAC0945L: Meningococcal vaccine serogroup unknown, unspecified
    VAC0997C: Pneumococcal polysaccharide conjugate vaccine, 13-valent, adsorbed,
      serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F
    VAC0997L: Pneumococcal 13-valent conjugate vaccine, unspecified
    VAC1037C: Tick-borne encephalitis vaccine, whole-virus inactivated, Neudörfl strain,
      pediatric dose
    VAC1037L: Tick-borne encephalitis vaccine, Neudörfl strain, paediatric dose, unspecified
    VAC1038C: Tick-borne encephalitis vaccine, whole-virus inactivated, Neudörfl strain,
      adult dose
    VAC1038L: Tick-borne encephalitis vaccine, Neudörfl strain, adult dose, unspecified
    VAC1039C: COVID-19 mRNA vaccine, original virus, 50 micrograms per dose
    VAC1039L: COVID-19 mRNA vaccine, original virus, 50 µg, unspecified
    VAC1041C: COVID-19 mRNA vaccine
    VAC1041L: COVID-19 mRNA vaccine, unspecified
    VAC1042C: COVID-19 vaccine, non-replicating viral vector
    VAC1042L: COVID-19 vaccine, non-replicating viral vector, unspecified
    VAC1043C: COVID-19 vaccine, protein subunit
    VAC1043L: COVID-19 vaccine, protein subunit, unspecified
    VAC1044C: COVID-19 vaccine, whole virion inactivated
    VAC1044L: COVID-19 vaccine, whole virion inactivated, unspecified
    VAC1062C: Cytomegalovirus immune globulin, intravenous
    VAC1062L: CMV immune globulin
    VAC1063C: Hepatitis C vaccine, unspecified
    VAC1063L: Hepatitis C vaccine, unspecified
    VAC1064C: HIV vaccine, unspecified
    VAC1064L: HIV vaccine, unspecified
    VAC1065C: Leprosy vaccine, unspecified
    VAC1065L: Leprosy vaccine
    VAC1066C: Melanoma vaccine, unspecified
    VAC1066L: Melanoma vaccine, unspecified
    VAC1067C: Streptococcus pyogenes vaccine, unspecified
    VAC1067L: Streptococcus pyogenes vaccine, unspecified
    VAC1068C: Rift Valley fever vaccine, unspecified
    VAC1068L: Rift Valley fever vaccine, unspecified
    VAC1069C: Vaccinia immune globulin
    VAC1069L: Vaccinia immune globulin
    VAC1071C: RSV antibody or vaccine, unspecified
    VAC1071L: RSV antibody or vaccine, unspecified
    VAC1072C: COVID-19 mRNA vaccine, original virus, 25 micrograms
    VAC1072L: COVID-19 mRNA vaccine, original virus, 25 µg, unspecified
    VAC1073C: Lyme disease vaccine, unspecified
    VAC1073L: Lyme disease vaccine, unspecified
    VAC1075C: Acellular anthrax vaccine, unspecified
    VAC1075L: Acellular anthrax vaccine, unspecified
    VAC1106C: Covid 19 VLP vaccine, unspecified
    VAC1106L: COVID-19 VLP vaccine, unspecified
    VAC1107C: Whole inactivated Cholera vaccine, unspecified
    VAC1107L: Whole inactivated Cholera vaccine, unspecified
    VAC1108C: Bivalent anti-covid 19 mRNA vaccine against the original virus and the
      Omicron BA.1 variant, unspecified
    VAC1108L: COVID-19 bivalent mRNA vaccine, original virus + Omicron BA.1 variant,
      unspecified
    VAC1109C: Non-conjugated polysaccharide vaccine against meningococci serogroups
      A, C and W
    VAC1109L: ACW unconjugated meningococcal vaccine, unspecified
    VAC1110C: Meningococcal C vaccine unconjugated, unspecified
    VAC1110L: Meningococcal C vaccine unconjugated, unspecified
    VAC1111C: Whole inactivated Japanese encephalitis vaccine, prepared in Vero cells
    VAC1111L: Japanese Encephalitis Vaccine, whole inactivated, prepared on Vero cells,
      unspecified
    VAC1112C: Live attenuated quadrivalent seasonal influenza vaccine, nasal
    VAC1112L: Live attenuated quadrivalent influenza vaccine, unspecified
    VAC1113C: Anti-covid 19 protein subunit vaccine, recombinant spike protein, unspecified
    VAC1113L: COVID-19 protein subunit vaccine, recombinant spike protein, unspecified
    VAC1114C: Typhoid vaccine combined with hepatitis A vaccine
    VAC1114L: Vaccine against typhoid fever and hepatitis A, unspecified
    VAC1115C: Pediatric diphtheria (toxoid, standard dose), tetanus (toxoid), pertussis
      (multicomponent acellular, standard dose), Haemophilus influenzae type b (tetanus
      toxoid conjugated) and polio (whole inactivated, trivalent) vaccine, adsorbed
    VAC1115L: Pentavalent vaccine DTPaHibP - Diphtheria-Tetanus-Pertussis-Hib PRP-Polio,
      unspecified
    VAC1116C: Whole inactivated rabies vaccine, prepared in Vero cell culture (PVRV),
      Wistar strain, inactivation by ß-propiolactone
    VAC1116L: Rabies vaccine, whole inactivated, prepared in Vero cell culture, unspecified
    VAC1117C: Bivalent anti-covid 19 mRNA vaccine against the original virus and the
      Omicron BA.4/5 variant, 5 micrograms, unspecified
    VAC1117L: COVID-19 bivalent mRNA vaccine against the original virus and the Omicron
      BA.4/5 variant, 5 micrograms, unspecified
    VAC1118C: Enterovirus A71 vaccine, unspecified
    VAC1118L: Enterovirus A71 vaccine, unspecified
    VAC1119C: COVID-19 inactivated vaccine, whole virus, authorized, unspecified
    VAC1119L: COVID-19 inactivated vaccine, whole virus, authorized, unspecified
    VAC1120C: Trivalent vaccine against leptospirosis caused by Canicola serovar canicola,
      Icterohaemorrhagiae serovar copenhageni and Pomona serovar mozdok
    VAC1120L: Trivalent leptospirosis vaccine, unspecified
    VAC1121C: Pediatric vaccine diphtheria (toxoid, standard dose), tetanus (toxoid),
      pertussis (acellular multicomponent, standard dose, 3 components), anti-Haemophilus
      influenzae type b (conjugated with tetanus toxoid), poliomyelitis (whole inactivated,
      trivalent) and hepatitis B (recombinant), unspecified
    VAC1121L: Hexavalent vaccine DTPaHibPHepB - Diphtheria-Tetanus-Pertussis-Hib-Polio-Hepatitis
      B 10µg, unspecified
    VAC1122C: First generation smallpox vaccine, live vaccinia virus
    VAC1122L: 1st generation live smallpox vaccine, unspecified
    VAC1123C: Live attenuated trivalent seasonal influenza vaccine, nasal
    VAC1123L: Live attenuated trivalent influenza vaccine, unspecified
    VAC1124C: COVID-19 inactivated vaccine, whole virus, in clinical trial, unspecified
    VAC1124L: Inactivated whole virus COVID-19 vaccine, in clinical trial, unspecified
    VAC1125C: Hepatitis B vaccine, unspecified
    VAC1125L: Hepatitis B vaccine, unspecified
    VAC1126C: Pediatric diphtheria (toxoid, standard dose), tetanus (toxoid), pertussis
      (whole inactivated), anti-Haemophilus influenzae type b (conjugated with tetanus
      toxoid) and polio (whole inactivated, trivalent) vaccine, unspecified
    VAC1126L: Pentavalent DTP Hib vaccine - Diphtheria-Tetanus-Pertussis-Hib PRP-Polio,
      unspecified
    VAC1127C: Immunoglobulin against hepatitis A, measles, chickenpox and rubella,
      unspecified
    VAC1127L: Immunoglobulin against hepatitis A, measles, chickenpox and rubella,
      unspecified
    VAC1128C: Plasmid DNA anti-covid 19 vaccine, unspecified
    VAC1128L: COVID-19 plasmid DNA vaccine, unspecified
    VAC1129C: Anti-covid 19 protein subunit vaccine, recombinant spike protein in
      nanoparticles, unspecified
    VAC1129L: COVID-19 protein subunit vaccine, recombinant spike protein in nanoparticles,
      unspecified
    VAC1130C: Trivalent inactivated seasonal influenza vaccine, split virion and tetanus
      (toxoid)
    VAC1130L: Trivalent inactivated seasonal influenza vaccine and tetanus toxoid,
      unspecified
    VAC1131C: Unconjugated pneumococcal polysaccharide vaccine, 17-valent, serotypes
      1, 2, 3, 4, 6A, 7F, 8, 9N, 11A, 12F, 14, 15F, 17F, 18C, 19F, 23F and 25
    VAC1131L: 17-valent unconjugated pneumococcal vaccine, unspecified
    VAC1132C: Bivalent anti-covid 19 mRNA vaccine against the original virus and the
      Omicron BA.4/5 variant, 1.5 micrograms, unspecified
    VAC1132L: COVID-19 bivalent mRNA vaccine, original virus + Omicron BA.4/5 variant,
      1.5 micrograms, unspecified
    VAC1133C: Quadrivalent meningococcal polysaccharide conjugate vaccine against
      serogroups A, C, W and Y (conjugated to CRM 197 protein)
    VAC1133L: Meningococcal ACWY polysaccharide conjugate vaccine, unspecified
    VAC1134C: Live attenuated vaccine against Argentine hemorrhagic fever, Junin virus,
      unspecified
    VAC1134L: Live attenuated vaccine against Argentine hemorrhagic fever, Junin virus,
      unspecified
    VAC1135C: Anti-covid 19 vaccine with non-replicating viral vector, adenovirus
      encoding the spike protein of SARS-CoV-2, by inhalation, unspecified
    VAC1135L: COVID-19 Plasmid DNA vaccine with non-replicating viral vector, adenovirus
      encoding the spike protein of SARS-CoV-2, by inhalation, unspecified
    VAC1136C: Pneumococcal polysaccharide conjugate vaccine, 23-valent, serotypes
      1, 2, 3, 4, 5, 6B, 7F, 8, 9N, 9V, 10A, 11A, 12F, 14, 15B, 17F, 18C, 19A, 19F,
      20, 22F, 23F and 33F
    VAC1136L: 23-valent Pneumococcus conjugate vaccine, unspecified
    VAC1137C: Whole inactivated tick-borne encephalitis vaccine, strain K23, unspecified
    VAC1137L: Whole inactivated tick-borne encephalitis vaccine, strain K23, unspecified
    VAC1138C: Recombinant protein subunit anti-covid 19 vaccine
    VAC1138L: COVID-19 recombinant protein subunit vaccine
    VAC1139C: COVID-19 vaccine, non-replicating vector, Newcastle disease virus encoding
      the SARS-CoV-2 spike protein, unspecified
    VAC1139L: COVID-19 vaccine, non-replicating vector, Newcastle disease virus encoding
      the SARS-CoV-2 spike protein, unspecified
    VAC1140C: Covid 19 bivalent mRNA vaccine against the original virus and the Omicron
      BA.4/5 variant, 25 micrograms, unspecified
    VAC1140L: COVID-19 bivalent mRNA vaccine against the original virus and the Omicron
      BA.4/5 variant, 25 micrograms, unspecified
    VAC1141C: Bird Flu H5N8 Vaccine, unspecified
    VAC1141L: Bird Flu H5N8 Vaccine, unspecified
    VAC1142C: COVID-19 vaccine, non-replicating vector, antigen-presenting cells,
      unspecified
    VAC1142L: COVID-19 vaccine, non-replicating vector, antigen-presenting cells,
      unspecified
    VAC1143C: Anti-covid 19 vaccine with non-replicating viral vector, adenovirus
      encoding the spike protein of SARS-CoV-2, unspecified
    VAC1143L: COVID-19 vaccine with non-replicating viral vector, adenovirus encoding
      the spike protein of SARS-CoV-2, unspecified
    VAC1144C: Anti-covid 19 protein subunit vaccine, recombinant SARS-CoV-2 spike
      protein, S-2P and CpG1018, unspecified
    VAC1144L: COVID-19 protein subunit vaccine, recombinant SARS-CoV-2 spike protein,
      S-2P and CpG1018, unspecified
    VAC1145C: Recombinant hepatitis B vaccine, three antigens (HbS, pre-S1 and pre-S2)
    VAC1145L: Recombinant hepatitis B vaccine, three antigens, unspecified
    VAC1146C: Inactivated quadrivalent influenza vaccine, split or subunit, high dose
    VAC1146L: Inactivated quadrivalent influenza vaccine, high dose, unspecified
    VAC1147C: Human monoclonal antibody against respiratory syncytial virus (RSV),
      nirsevimab, unspecified
    VAC1147L: Human monoclonal antibody against respiratory syncytial virus (RSV),
      nirsevimab, unspecified
    VAC1148C: Haemophilus influenzae type b vaccine, unconjugated polysaccharide,
      unspecified
    VAC1148L: Haemophilus influenzae type b vaccine, unconjugated polysaccharide,
      unspecified
    VAC1149C: Oral live attenuated cholera vaccine, unspecified
    VAC1149L: Oral live attenuated cholera vaccine, unspecified
    VAC1150C: Anti-covid 19 mRNA vaccine encoding the spike protein of SARS-CoV-2,
      original virus, 30 micrograms, unspecified
    VAC1150L: COVID-19 mRNA vaccine encoding the spike protein of SARS-CoV-2, original
      virus, 30 micrograms, unspecified
    VAC1151C: Pediatric diphtheria (toxoid, standard dose), tetanus (toxoid), pertussis
      (whole inactivated), and polio (whole inactivated, trivalent) vaccine
    VAC1151L: Quadrivalent DTPeP vaccine - Diphtheria-Tetanus-Pertussis-Polio, unspecified
    VAC1152C: Meningococcal B vaccine containing fHbp of subfamilies A and B, unspecified
    VAC1152L: Meningococcal B vaccine containing fHbp of subfamilies A and B, unspecified
    VAC1153C: Quadrivalent meningococcal polysaccharide conjugate vaccine against
      serogroups A, C, W and Y (diphtheria toxoid conjugate)
    VAC1153L: Quadrivalent meningococcal ACWY vaccine, diphtheria toxoid conjugate,
      unspecified
    VAC1154C: Whole inactivated mumps vaccine, unspecified
    VAC1154L: Whole inactivated mumps vaccine, unspecified
    VAC1155C: Plasma hepatitis B vaccine, unspecified
    VAC1155L: Plasma hepatitis B vaccine, unspecified
    VAC1156C: Intravenous human immunoglobulin against infant botulism types A and
      B
    VAC1156L: Immunoglobulin against botulism, unspecified
    VAC1157C: Third generation smallpox vaccine, modified vaccinia Ankara virus, non-replicating
    VAC1157L: 3rd generation smallpox vaccine, modified Ankara vaccinia virus, unspecified
    VAC1158C: COVID-19 mRNA vaccine encoding the SARS-CoV-2 spike protein, Omicron
      XBB.1.5 variant, 3 micrograms
    VAC1158L: COVID-19 mRNA vaccine against the Omicron XBB.1.5 variant, 3 micrograms,
      unspecified
    VAC1159C: Trivalent Recombinant Seasonal Influenza Vaccine
    VAC1159L: Recombinant trivalent influenza vaccine, unspecified
    VAC1160C: Second generation smallpox vaccine, vaccinia virus obtained by cell
      culture
    VAC1160L: 2nd generation live smallpox vaccine, unspecified
    VAC1161C: Pediatric diphtheria (toxoid, standard dose), tetanus (toxoid), pertussis
      (whole inactivated) and Haemophilus influenzae type b (tetanus toxoid conjugated)
      vaccine
    VAC1161L: Quadrivalent DTPeP vaccine - Diphtheria-Tetanus-Pertussis-Hib PRP, unspecified
    VAC1162C: COVID-19 mRNA vaccine, bivalent, original virus and Omicron BA.1 variant,
      15 micrograms, unspecified
    VAC1162L: COVID-19 mRNA vaccine, bivalent, original virus and Omicron BA.1 variant,
      15 micrograms, unspecified
    VAC1163C: Pneumococcal polysaccharide conjugate vaccine, 20-valent, adsorbed,
      serotypes 1, 3, 4, 5, 6A, 6B, 7F, 8, 9V, 10A, 11A, 12F, 14, 15B, 18C, 19A, 19F,
      22F, 23F and 33F
    VAC1163L: 20-valent Pneumococcus conjugate vaccine, unspecified
    VAC1164C: Pediatric diphtheria (toxoid, standard dose), tetanus (toxoid), pertussis
      (acellular multicomponent, standard dose) and Haemophilus influenzae type b
      (tetanus toxoid conjugate) vaccine
    VAC1164L: Quadrivalent DTPaHib- Diphtheria-Tetanus-Pertussis-Hib PRP vaccine,
      unspecified
    VAC1165C: Pediatric diphtheria vaccine (toxoid, standard dose)
    VAC1165L: Diphtheria toxoid, standard dose, unspecified
    VAC1166C: Anti-covid 19 mRNA vaccine encoding the SARS-CoV-2 spike protein, currently
      in clinical trial, unspecified
    VAC1166L: COVID-19 mRNA vaccine encoding the SARS-CoV-2 spike protein, currently
      in clinical trial, unspecified
    VAC1167C: Acellular pertussis vaccine, standard dose
    VAC1167L: Acellular Pertussis Vaccine, unspecified
    VAC1168C: Pediatric diphtheria (toxoid, standard dose), tetanus (toxoid), pertussis
      (whole inactivated) and Haemophilus influenzae type b (diphtheria toxoid conjugate)
      vaccine
    VAC1168L: Quadrivalent DTPeHib- Diphtheria-Tetanus-Pertussis-Hib OC vaccine, unspecified
    VAC1169C: Bivalent anti-covid 19 mRNA vaccine against the original virus and the
      Omicron BA.4/5 variant, 15 micrograms, unspecified
    VAC1169L: COVID-19 Bivalent mRNA vaccine, original virus + Omicron BA.4/5 variant,
      15 micrograms, unspecified
    VAC1170C: Non-replicating viral vector anti-covid 19 vaccine, chimpanzee adenovirus
      ChadOx1 encoding the SARS-CoV-2 spike protein
    VAC1170L: Non-replicating viral vector COVID-19 vaccine, chimpanzee adenovirus
      ChadOx1 encoding the SARS-CoV-2 spike protein
    VAC1171C: Trivalent inactivated influenza vaccine, split or subunit, high dose
    VAC1171L: Inactivated trivalent influenza vaccine, high dose, unspecified
    VAC1172C: Diphtheria vaccine (anatoxin, reduced dose)
    VAC1172L: Diphtheria toxoid, reduced dose, unspecified
    VAC1173C: Anti-covid 19 vaccine with replicative viral vector, influenza virus
      encoding the spike protein of SARS-CoV-2, unspecified
    VAC1173L: COVID-19 vaccine with replicative viral vector, influenza virus encoding
      the spike protein of SARS-CoV-2, unspecified
    VAC1174C: Pediatric diphtheria (toxoid, standard dose), tetanus (toxoid), pertussis
      (multicomponent acellular, standard dose), polio (whole inactivated, trivalent)
      and hepatitis B (recombinant) vaccine
    VAC1174L: Pentavalent DTPaPHepB vaccine - Diphtheria-Tetanus-Pertussis-Polio-Hepatitis
      B 10µg, unspecified
    VAC1175C: Trivalent inactivated cell culture influenza vaccine, split or subunit,
      normal dose
    VAC1175L: Inactivated trivalent influenza vaccine cell culture, normal dose, unspecified
    VAC1176C: Anti-covid 19 vaccine with non-replicating viral vector, adenovirus
      5 encoding the S and N proteins of SARS-CoV-2, unspecified
    VAC1176L: COVID-19 vaccine with non-replicating viral vector, adenovirus 5 encoding
      the S and N proteins of SARS-CoV-2, unspecified
    VAC1177C: Third generation smallpox vaccine, obtained in cell culture, minimally
      replicating live vaccinia virus
    VAC1177L: 3rd generation smallpox vaccine, live vaccinia virus with minimal replication,
      unspecified
    VAC1178C: Live attenuated, chimeric, recombinant, quadrivalent vaccine against
      the four serotypes (1, 2, 3 and 4) of dengue virus
    VAC1178L: Tetravalent Dengue vaccine, live attenuated chimeric recombinant, unspecified
    VAC1179C: Cholera (whole inactivated) and typhoid vaccine (unconjugated, purified
      Vi polysaccharide antigen), injectable
    VAC1179L: Cholera and typhoid vaccine, injectable, unspecified
    VAC1180C: Recombinant anti-Borrelia burgdorferi vaccine - outer surface protein
      A (OspA)
    VAC1180L: Recombinant Lyme disease vaccine, unspecified
    VAC1181C: Pediatric diphtheria (toxoid, standard dose), tetanus (toxoid), pertussis
      (whole intact), Haemophilus influenzae type b (tetanus toxoid conjugated) and
      hepatitis B (recombinant) vaccine
    VAC1181L: Pentavalent vaccine DTPeHibHepB - Diphtheria-Tetanus-Pertussis-Hib PRP-HepatitisB
      10µg, unspecified
    VAC1182C: Quadrivalent polysaccharide conjugate vaccine against meningococci serogroups
      A, C, W and Y (conjugated with tetanus toxoid)
    VAC1182L: Meningococcal ACWY polysaccharide vaccine conjugated to tetanus toxoid,
      unspecified
    VAC1183C: Non-replicating viral vector Ebola vaccine, modified Vaccine Ankara
    VAC1183L: Non-replicating viral vector Ebola vaccine, unspecified
    VAC1184C: Meningococcal C polysaccharide vaccine conjugated to tetanus toxoid,
      unspecified
    VAC1184L: Meningococcal C polysaccharide vaccine conjugated to tetanus toxoid,
      unspecified
    VAC1185C: Anti-covid 19 vaccine with non-replicating viral vector, adenovirus
      26 encoding the spike protein of SARS-CoV-2, unspecified
    VAC1185L: COVID-19 vaccine with non-replicating viral vector, adenovirus 26 encoding
      the spike protein of SARS-CoV-2, unspecified
    VAC1186C: Anti-covid 19 vaccine with replicative viral vector with antigen-presenting
      cells, unspecified
    VAC1186L: COVID-19 vaccine with replicative viral vector with antigen-presenting
      cells, unspecified
    VAC1187C: Anti-covid 19 vaccine with replicative viral vector, measles virus encoding
      the SARS-CoV-2 spike protein, unspecified
    VAC1187L: COVID-19 vaccine with replicative viral vector, measles virus encoding
      the SARS-CoV-2 spike protein, unspecified
    VAC1188C: Anti-covid 19 mRNA vaccine encoding the spike protein of SARS-CoV-2,
      original virus, 3 micrograms, unspecified
    VAC1188L: COVID-19 mRNA vaccine encoding the spike protein of SARS-CoV-2, original
      virus, 3 micrograms, unspecified
    VAC1189C: Non-replicating vector anti-covid 19 vaccine, modified Ankara vaccine
      encoding the SARS-CoV-2 spike protein, unspecified
    VAC1189L: Non-replicating vector COVID-19 vaccine, modified Ankara vaccine encoding
      the SARS-CoV-2 spike protein, unspecified
    VAC1190C: Anti-covid 19 vaccine with replicative viral vector, vesicular stomatitis
      virus encoding the SARS-CoV-2 spike protein, unspecified
    VAC1190L: COVID-19 vaccine with replicative viral vector, vesicular stomatitis
      virus encoding the SARS-CoV-2 spike protein, unspecified
    VAC1191C: Vaccine against Escherichia coli, Klebsiella pneumoniae, Enterococcus
      faecalis, Proteus vulgaris
    VAC1191L: Vaccine for the prevention of urinary infections in women, unspecified
    VAC1192C: Pediatric diphtheria (toxoid, standard dose), tetanus (toxoid), pertussis
      (whole inactivated), Haemophilus influenzae type b (diphtheria toxoid conjugated)
      and hepatitis B (recombinant) vaccine
    VAC1192L: Pentavalent vaccine DTPePHibHepB - Diphtheria-Tetanus-Pertussis-Hib
      OC-HepatitisB 10µg, unspecified
    VAC1193C: Live attenuated Japanese encephalitis vaccine, chimeric recombinant
    VAC1193L: Japanese encephalitis vaccine, live recombinant attenuated, unspecified
    VAC1194C: Tetanus (toxoid), typhoid (whole inactivated) and paratyphoid A and
      B (whole inactivated) vaccines
    VAC1194L: Tetanus, typhoid and paratypoid A and B vaccines, unspecified
    VAC1195C: Anti-covid 19 vaccine with non-replicating viral vector, adenovirus
      26 encoding the spike protein of SARS-CoV-2, in clinical trial, unspecified
    VAC1195L: COVID-19 vaccine with non-replicating viral vector, adenovirus 26 encoding
      the spike protein of SARS-CoV-2, in clinical trial, unspecified
    VAC1196C: Whole inactivated vaccine against Japanese encephalitis, prepared from
      murine brain tissue, Nakayama strain, injectable route
    VAC1196L: Japanese encephalitis vaccine, whole inactivated prepared from murine
      brain tissue, unspecified
    VAC1197C: 'COVID-19 vaccine with chimpanzee adenovirus and self-amplifying mRNA:
      1. A non-replicating viral vector, chimpanzee adenovirus, serotype 68 (ChAdV68),
      encoding the spike protein of SARS-CoV-2 (ChAdV68-S) and/or spike protein plus
      additional SARS-CoV-2 epitopes recognized by T cells (ChAdV68-S-TCE) and 2.
      A self-amplifying mRNA (SAM) in lipid nanoparticles (SAM-LNP) encoding SARS-CoV-2
      spike protein (SAM-S) and/or spike protein plus additional SARS-CoV-2 epitopes
      recognized by T cells (SAM-S-TCE), SAM vector based on Venezuelan equine encephalitis
      virus (VEEV)'
    VAC1197L: COVID-19 vaccine with chimpanzee adenovirus and self-amplifying mRNA,
      unspecified
    VAC1198C: Live attenuated chikungunya vaccine
    VAC1198L: Chinkungunya vaccine, live attenuated, unspecified
    VAC1199C: Recombinant vesicular stomatitis replicative viral vector Ebola vaccine
      (rVSV) - EBOV GP glycoprotein, unspecified
    VAC1199L: Recombinant vesicular stomatitis replicative viral vector Ebola vaccine
      (rVSV) - EBOV GP glycoprotein, unspecified
    VAC1200C: Quadrivalent inactivated cell culture influenza vaccine, split or subunit,
      normal dose
    VAC1200L: Quadrivalent influenza vaccine, on cell culture, unspecified
    VAC1201C: Tetravalent Dengue vaccine, live attenuated chimeric recombinant based
      on 17D yellow fever vaccine, unspecified
    VAC1201L: Tetravalent Dengue vaccine, live attenuated chimeric recombinant based
      on 17D yellow fever vaccine, unspecified
    VAC1202C: Anti-covid 19 vaccine with live attenuated virus, unspecified
    VAC1202L: COVID-19 vaccine with live attenuated virus, unspecified
    VAC1203C: P.I. (phenol-insoluble) protein antigen vaccine against brucellosis
    VAC1203L: Brucellosis vaccine, protein (P.I. antigen)
    VAC1204C: Anti-covid 19 protein subunit vaccine, recombinant spike protein, with
      adjuvant, unspecified
    VAC1204L: COVID-19 protein subunit vaccine, recombinant spike protein, with adjuvant,
      unspecified
    VAC1205C: Ebola virus vaccine, recombinant live non-replicating viral vector Ad26.ZEBOV,
      unspecified
    VAC1205L: Ebola virus vaccine, recombinant live non-replicating viral vector Ad26.ZEBOV,
      unspecified
    VAC1206C: Anti-covid 19 vaccine with self-amplifying mRNA, unspecified
    VAC1206L: COVID-19 vaccine with self-amplifying mRNA, unspecified
    VAC1207C: COVID-19 vaccine with replicative viral vector, Newcastle disease virus
      encoding the SARS-CoV-2 spike protein, unspecified
    VAC1207L: COVID-19 vaccine with replicative viral vector, Newcastle disease virus
      encoding the SARS-CoV-2 spike protein, unspecified
    VAC1208C: Pediatric diphtheria (toxoid, standard dose), tetanus (toxoid), pertussis
      (whole inactivated) and hepatitis B (recombinant) vaccine, adsorbed
    VAC1208L: Quadrivalent DTPeHepB vaccine - Diphtheria-Tetanus-Pertussis-HepatitisB
      10µg, unspecified
    VAC1209C: Whole inactivated measles vaccine (historical)
    VAC1209L: Measles vaccine, whole inactivated, unspecified
    VAC1210C: COVID-19 mRNA vaccine encoding the SARS-CoV-2 spike protein, original
      virus, 100 micrograms, unspecified
    VAC1210L: COVID-19 mRNA vaccine encoding the SARS-CoV-2 spike protein, original
      virus, 100 micrograms, unspecified
    VAC1211C: Meningococcal C vaccine, polysaccharide conjugated to CRM197 protein
    VAC1211L: Meningococcal C polysaccharide vaccine conjugated to CRM197 protein,
      unspecified
    VAC1212C: Polio vaccine (whole inactivated, trivalent), oral
    VAC1212L: Trivalent Poliomyelitis vaccine, whole inactivated oral, unspecified
    VAC1213C: Cholera vaccine containing recombinant cholera toxin B subunit and inactivated
      whole V. cholerae O1 bacteria, unspecified
    VAC1213L: Cholera vaccine containing recombinant cholera toxin B subunit and inactivated
      whole V. cholerae O1 bacteria, unspecified
    VAC1214C: COVID-19 mRNA vaccine encoding the SARS-CoV-2 spike protein, against
      the Omicron XBB.1.5 variant, 10µg
    VAC1214L: COVID-19 mRNA vaccine encoding the SARS-CoV-2 spike protein, against
      the Omicron XBB.1.5 variant, 10µg, unspecified
    VAC1215C: Pediatric vaccine diphtheria (toxoid, standard dose), tetanus (toxoid),
      pertussis (multicomponent acellular, standard dose), anti-Haemophilus influenzae
      type b (conjugated to the outer membrane protein of Neisseria meningitidis serogroup
      B), poliomyelitis (whole inactivated, trivalent) and hepatitis B (recombinant),
      adsorbed
    VAC1215L: Hexavalent vaccine DTPaHibPHepB - Diphtheria-Tetanus-Pertussis-Hib OMP-Polio-Hepatitis
      B 10µg, unspecified
    VAC1216C: Pediatric diphtheria (toxoid, standard dose), tetanus (toxoid), pertussis
      (multicomponent acellular, standard dose) and hepatitis B (recombinant) vaccine
    VAC1216L: Quadrivalent DTPaHepB vaccine - Diphtheria-Tetanus-Pertussis-Hepatitis
      B 10µg, unspecified
    VAC1217C: Hepatitis B and Haemophilus influenzae type b vaccine, capsular polysaccharide
      (polyribosylribitol phosphate, PRP) conjugated to the outer membrane protein
      of Neisseria meningitidis serogroup B
    VAC1217L: Vaccine against hepatitis B and Haemophilus influenzae type b, unspecified
    VAC1218C: Meningococcal polysaccharide conjugate vaccine with tetanus toxoid against
      serogroup A
    VAC1218L: Meningococcal A polysaccharide vaccine conjugated to tetanus toxoid,
      unspecified
    VAC1219C: Pediatric diphtheria (toxoid, standard dose), tetanus (toxoid), pertussis
      (whole inactivated), Haemophilus influenzae type b (tetanus toxoid conjugated)
      and meningococcal serogroups A and C (toxoid conjugate) vaccine tetanus)
    VAC1219L: Hexavalent vaccine DTPeHibMCV-A-C-T - Diphtheria-Tetanus-Pertussis-Hib
      PRP-Meningococcus A and C, conjugated with tetanus toxoid, unspecified
    VAC1220C: Conjugate vaccine against Haemophilus influenzae type b (conjugated
      with tetanus toxoid) and against meningococci serogroups C and Y (conjugated
      with tetanus toxoid)
    VAC1220L: Meningococcal CY and anti-Haemophilus influenzae type b vaccine, conjugated
      with tetanus toxoid, unspecified
    VAC1221C: Pediatric diphtheria (toxoid, standard dose), tetanus (toxoid) and rubella
      vaccine (live attenuated)
    VAC1221L: Trivalent vaccine against diphtheria, tetanus and rubella, unspecified
    VAC1222C: Human monoclonal antibody against respiratory syncytial virus (RSV),
      palivizumab, unspecified
    VAC1222L: Human monoclonal antibody against respiratory syncytial virus (RSV),
      palivizumab, unspecified
    VAC1223C: Immunoglobulin against respiratory syncytial virus (RSV), unspecified
    VAC1223L: Immunoglobulin against respiratory syncytial virus (RSV), unspecified
    VAC1224C: Respiratory syncytial virus (RSV) vaccine, recombinant, F-glycoprotein
      (prefusion), bivalent (RSV subtypes A and B), unspecified
    VAC1224L: Respiratory syncytial virus (RSV) vaccine, recombinant, F-glycoprotein
      (prefusion) RSV subtypes A and B, unspecified
    VAC1225C: Diphtheria, tetanus (toxoid), typhoid (whole inactivated) and paratyphoid
      A and B (whole inactivated) vaccines
    VAC1225L: DT-TAB Diphtheria, tetanus, typhoid and paratypoid A and B vaccines,
      unspecified
    VAC1226C: Combined hepatitis A and B vaccine, pediatric dose, unspecified
    VAC1226L: Combined hepatitis A and B vaccine, pediatric dose, unspecified
    VAC1227C: Hepatitis B vaccine, recombinant hepatitis B virus surface antigen (HBsAg),
      5 micrograms
    VAC1227L: Recombinant hepatitis B vaccine, pediatric dose, unspecified
    VAC1228C: Respiratory syncytial virus (RSV) vaccine, recombinant, F protein-derived
      RSVPreF3 antigen, unspecified
    VAC1228L: Respiratory syncytial virus (RSV) vaccine, recombinant, F protein-derived
      RSVPreF3 antigen, unspecified
    VAC1229C: Vaccine against meningococcal serogroups B (outer membrane vesicle proteins
      B:14:P1.7,16) and C
    VAC1229L: Vaccine against meningococcal serogroups B (outer membrane vesicle proteins)
      and C
    VAC1230C: Conjugate vaccine against Haemophilus influenzae type b (conjugated
      with tetanus toxoid) and against meningococci serogroup C (conjugated with tetanus
      toxoid)
    VAC1230L: Meningococcal C and anti-Haemophilus influenzae type b vaccine, conjugated
      with tetanus toxoid, unspecified
    VAC1231C: Pediatric diphtheria (toxoid, standard dose), tetanus (toxoid), pertussis
      (multicomponent acellular, standard dose), hepatitis B and Haemophilus influenzae
      type b (tetanus toxoid conjugate) vaccine
    VAC1231L: Pentavalent vaccine DTPaHibHepB- Diphtheria-Tetanus-Pertussis-Hib PRP-Hepatitis
      B 10μg, unspecified
    VAC1232C: Acellular pertussis vaccine, reduced dose
    VAC1232L: Acellular pertussis vaccine, reduced dose, unspecified
    VAC1233C: Pneumococcal polysaccharide conjugate vaccine, 10-valent, serotypes
      1, 4, 5, 6B, 7F, 9V, 14, 18C, 19F and 23F
    VAC1233L: 10-valent Pneumococcus conjugate vaccine, unspecified
    VAC1234C: Unconjugated pneumococcal polysaccharide vaccine, 15-valent, serotypes
      1, 2, 3, 4, 6B, 7F, 8, 9N, 11A, 12F, 14, 15F, 18C, 19F and 23F
    VAC1234L: 15-valent unconjugated pneumococcal vaccine, unspecified
    VAC1235C: RIX4414 monovalent rotavirus vaccine, unspecified
    VAC1235L: RIX4414 monovalent rotavirus vaccine, unspecified
    VAC1236C: COVID-19 spike protein subunit vaccine, recombinant spike protein in
      nanoparticles, Omicron subvariant XBB.1.5
    VAC1236L: COVID-19 protein subunit vaccine, recombinant spike protein in nanoparticles,
      Omicron subvariant XBB.1.5, unspecified
    VAC1237C: Pre-erythrocytic malaria vaccine R21/Matrix-M
    VAC1237L: Pre-erythrocytic malaria vaccine, unspecified
    VAC1238C: Vaccine against hepatitis B and malaria, unspecified
    VAC1238L: Vaccine against hepatitis B and malaria, unspecified
    VAC1239C: Pneumococcal polysaccharide conjugate vaccine, 15-valent, adsorbed,
      serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, 22F, 23F and 33F
    VAC1239L: 15-valent Pneumococcus conjugate vaccine, unspecified
    VAC1240C: 4-component serogroup B meningococcal vaccine
    VAC1240L: 4-component meningococcal B vaccine, unspecified
    VAC1241C: Shingles vaccine, varicella-zoster virus (VZV) surface glycoprotein
      E (gE), unspecified
    VAC1241L: Shingles vaccine, varicella-zoster virus (VZV) surface glycoprotein
      E (gE), unspecified
    VAC1242C: COVID-19 mRNA vaccine encoding the SARS-CoV-2 spike protein, Omicron
      XBB.1.5 variant, 25 micrograms
    VAC1242L: COVID-19 mRNA vaccine encoding the SARS-CoV-2 spike protein, Omicron
      XBB.1.5 variant, 25 micrograms
    VAC1243C: COVID-19 mRNA vaccine encoding the SARS-CoV-2 spike protein, Omicron
      XBB.1.5 variant, 50 micrograms
    VAC1243L: COVID-19 mRNA vaccine encoding the SARS-CoV-2 spike protein, Omicron
      XBB.1.5 variant, 50 micrograms
    VAC1244C: COVID-19 mRNA vaccine encoding the SARS-CoV-2 spike protein, Omicron
      XBB.1.5 variant, 30 micrograms
    VAC1244L: COVID-19 mRNA vaccine encoding the SARS-CoV-2 spike protein, Omicron
      XBB.1.5 variant, 30 micrograms
    VAC1245C: Meningococcal vaccine against serogroups A, C, W and Y (polysaccharide
      conjugated to tetanus toxoid), and against serogroup B (recombinant)
    VAC1245L: ABCWY meningococcal vaccine, unspecified
    VAC1247C: Hepatitis A vaccine, unspecified
    VAC1247L: Hepatitis A vaccine, unspecified
    VAC1248C: Combined influenza and Covid 19 mRNA vaccine, unspecified
    VAC1248L: Influenza/Covid 19 mRNA vaccine, unspecified
    VAC1249C: Trivalent inactivated influenza vaccine, split or subunit, intradermal
      route, unspecified
    VAC1249L: Flu vaccine, trivalent inactivated, high dose, intradermal use, unspecified
    VAC1256C: Diphtheria toxoid (standard dose), tetanus toxoid, pertussis (whole
      cell), Haemophilus influenzae type b (conjugated to tetanus toxoid), inactivated
      polio (trivalent) and hepatitis B (recombinant) pediatric vaccine, adsorbed
    VAC1256L: Hexavalent vaccine DTwPHibPHepB - Diphtheria-Tetanus-Pertussis-Hib-Polio-Hepatitis
      B 15µg, unspecified
    VAC1257C: Cholera vaccine, oral, bivalent consisting of killed whole cells of
      Vibrio cholerae O1 (classical and El Tor) and O139
    VAC1257L: Cholera vaccine, whole inactivated oral, bivalent containing the whole
      inactivated V. cholerae O1 and O139 bacteria, unspecified
    VAC1263C: COVID-19 mRNA vaccine encoding the SARS-COV-2 spike protein, authorized
    VAC1263L: COVID-19 mRNA vaccine encoding the SARS-COV-2 spike protein, authorized
    VAC1264C: A(H5) avian influenza vaccine, neuraminidase type not specified
    VAC1264L: A(H5) avian influenza vaccine, unspecified
    VAC1277C: Vaccine against chikungunya, unspecified
    VAC1277L: Vaccine against chikungunya, unspecified
    VAC1279C: Adjuvanted adsorbed anthrax cell vaccine
    VAC1279L: Adjuvanted adsorbed anthrax vaccine
    VAC1280C: 21-valent pneumococcal conjugate vaccine, adsorbed, serotypes 3, 6A,
      7F, 8, 9N, 10A, 11A, 12F, 15A, 15B, 15C, 16F, 17F, 19A, 20A, 22F, 23A, 23B,
      24F, 31, 33F, 35B
    VAC1280L: 21-valent pneumococcal conjugate vaccine, unspecified
    VAC1311C: Quadrivalent meningococcal polysaccharide conjugate vaccine, serogroups
      A, C, W, X and Y
    VAC1311L: Meningococcal ACWXY conjugate vaccine, unspecified
    VAC1341C: COVID-19 mRNA vaccine encoding the SARS-CoV-2 spike protein, Omicron
      XBB.1.5 variant, unspecified dose
    VAC1341L: COVID-19 mRNA vaccine encoding the SARS-CoV-2 spike protein, Omicron
      XBB.1.5 variant, unspecified dose
    VAC1409C: COVID-19 mRNA vaccine, Omicron JN.1 subvariant, 50 micrograms per dose,
      multidose vial
    VAC1409L: COVID-19 mRNA vaccine, Omicron JN.1 subvariant, 50 micrograms per dose,
      multidose vial
    VAC1410C: COVID-19 mRNA vaccine, Omicron JN.1 subvariant, 25 micrograms per dose,
      multidose vial
    VAC1410L: COVID-19 mRNA vaccine, Omicron JN.1 subvariant, 25 micrograms per dose,
      multidose vial
    VAC1411C: COVID-19 mRNA vaccine, subvariant Omicron JN.1, 30 micrograms, adult
      dose (+ 12 years)
    VAC1411L: COVID-19 mRNA vaccine, subvariant Omicron JN.1, 30 micrograms, adult
      dose (+ 12 years)
    VAC1412C: COVID-19 mRNA vaccine, subvariant Omicron JN.1, 10 micrograms, paediatric
      dose (5-11 years)
    VAC1412L: COVID-19 mRNA vaccine, subvariant Omicron JN.1, 10 micrograms, paediatric
      dose (5-11 years)
    VAC1413C: COVID-19 mRNA vaccine, subvariant Omicron JN.1, 3 micrograms, dose (6
      months-4 years)
    VAC1413L: COVID-19 mRNA vaccine, subvariant Omicron JN.1, 3 micrograms, dose (6
      months-4 years)
    VAC1414C: COVID-19 vaccine, protein subunit, recombinant spike protein nanoparticles,
      with adjuvant (Matrix M), Omicron JN.1 subvariant
    VAC1414L: COVID-19 vaccine, protein subunit, recombinant spike protein nanoparticles,
      with adjuvant (Matrix M), Omicron JN.1 subvariant
    VAC1415C: Polyvalent vaccine against  pus bacterium Pseudomonas aeruginosa
    VAC1415L: Polyvalent vaccine against  pus bacterium Pseudomonas aeruginosa
    VAC1416C: COVID-19 mRNA vaccine, subvariant Omicron KP.2, 3 micrograms, paediatric
      dose (6 months-4 years)
    VAC1416L: COVID-19 mRNA vaccine, subvariant Omicron KP.2, 3 micrograms, paediatric
      dose (6 months-4 years)
    VAC1417C: COVID-19 mRNA vaccine, subvariant Omicron KP.2, 10 micrograms, paediatric
      dose (5-11 years)
    VAC1417L: COVID-19 mRNA vaccine, subvariant Omicron KP.2, 10 micrograms, paediatric
      dose (5-11 years)
    VAC1418C: COVID-19 mRNA vaccine, subvariant Omicron KP.2, 30 micrograms, adult
      (+ 12 years)
    VAC1418L: COVID-19 mRNA vaccine, subvariant Omicron KP.2, 30 micrograms, adult
      (+ 12 years)
    VAC1419C: Chikungunya VLP vaccine (recombinant, adsorbed)
    VAC1419L: Chikungunya VLP vaccine (recombinant, adsorbed)
    VAC1420C: Single-stranded 5' capped mRNA encoding the Respiratory syncytial virus
      glycoprotein F stabilized in the prefusion conformation
    VAC1420L: Single-stranded 5' capped mRNA encoding the Respiratory syncytial virus
      glycoprotein F stabilized in the prefusion conformation
    VAC1421C: COVID-19 vaccine, mRNA encoding the SARS-CoV-2 spike protein, original
      virus
    VAC1421L: COVID-19 vaccine, mRNA encoding the SARS-CoV-2 spike protein, original
      virus
    VAC1422C: COVID-19 protein subunit vaccine, recombinant N protein
    VAC1422L: COVID-19 protein subunit vaccine, recombinant N protein
    VAC1423C: Live attenuated influenza A(H1N1)pdm09 pandemic vaccine
    VAC1423L: Live attenuated influenza A(H1N1)pdm09 pandemic vaccine
    VAC1424C: 10-valent pneumococcal polysaccharide conjugate vaccine, serotypes 1,
      5, 6A, 6B, 7F, 9V, 14, 19A, 19F and 23F
    VAC1424L: 10-valent pneumococcal polysaccharide conjugate vaccine, serotypes 1,
      5, 6A, 6B, 7F, 9V, 14, 19A, 19F and 23F
    VAC1425C: Typhoid vaccine, Vi antigen conjugated to CRM197 protein
    VAC1425L: Typhoid vaccine, Vi antigen conjugated to CRM197 protein
    VAC1426C: Bivalent recombinant vaccine against human papillomavirus (types 16
      and 18) (Pichia pastoris)
    VAC1426L: Bivalent recombinant vaccine against human papillomavirus (types 16
      and 18) (Pichia pastoris)
    VAC1427C: Whole inactivated Japanese encephalitis vaccine, prepared in Vero cells,
      6 micrograms
    VAC1427L: Whole inactivated Japanese encephalitis vaccine, prepared in Vero cells,
      6 micrograms
    VAC1428C: COVID-19 vaccine, protein subunit, recombinant homodimeric RBD protein,
      Omicron variant XBB.1.16, with adjuvant (SQBA)
    VAC1428L: COVID-19 vaccine, protein subunit, recombinant homodimeric RBD protein,
      Omicron variant XBB.1.16, with adjuvant (SQBA)
    VAC1430C: COVID-19 bivalent mRNA vaccine against the original virus and the Omicron
      BA.4/5 variant, 50 micrograms, unspecified
    VAC1430L: COVID-19 bivalent mRNA vaccine against the original virus and the Omicron
      BA.4/5 variant, 50 micrograms, unspecified
    VAC1431C: RSV vaccine, unspecified
    VAC1431L: RSV vaccine, unspecified
    VAC1432C: Argentine hemorrhagic fever vaccine, Junin virus, unspecified
    VAC1432L: Argentine hemorrhagic fever vaccine, Junin virus, unspecified
    VAC1433C: Plague vaccine, unspecified
    VAC1433L: Plague vaccine, unspecified
    VAC1434C: Meningococcal A vaccine, unspecified
    VAC1434L: Meningococcal A vaccine, unspecified
    VAC1435C: Rabies valence, inactivated, whole virion, cell culture-based, unspecified
    VAC1435L: Rabies vaccine, inactivated, whole virion, cell culture-based, unspecified
    VAC1436C: Rabies vaccine, inactivated, whole virion, prepared from animal brain
      tissue infected with rabies virus, unspecified
    VAC1436L: Rabies vaccine, inactivated, whole virion, prepared from animal brain
      tissue infected with rabies virus, unspecified
    VAC1437C: Meningococcal vaccine, monovalent, conjugate
    VAC1437L: Meningococcal vaccine, monovalent, conjugate
    VAC1438C: Influenza vaccine, trivalent, inactivated, fractionated or subunit,
      adjuvanted
    VAC1438L: Influenza vaccine, trivalent, inactivated, fractionated or subunit,
      adjuvanted
    VAC1439C: Meningococcal vaccine, polyvalent, conjugate polysaccharide
    VAC1439L: Meningococcal vaccine, polyvalent, conjugate polysaccharide
    VAC1440C: Influenza valence, quadrivalent, inactivated, fractionated or subunit,
      adjuvanted, normal dose
    VAC1440L: Influenza vaccine, quadrivalent, inactivated, fractionated or subunit,
      adjuvanted, normal dose
    VAC1441C: Influenza vaccine, quadrivalent, inactivated, split or subunit, intradermal
      route, unspecified
    VAC1441L: Influenza vaccine, quadrivalent, inactivated, split or subunit, intradermal
      route, unspecified
    VAC1442C: Influenza vaccine, quadrivalent, virosomal, unspecified
    VAC1442L: Influenza vaccine, quadrivalent, virosomal, unspecified
    VAC1443C: Influenza vaccine, trivalent, virosomal, unspecified
    VAC1443L: Influenza vaccine, trivalent, virosomal, unspecified
    VAC1444C: Influenza vaccine, trivalent, VLP, unspecified
    VAC1444L: Influenza vaccine, trivalent, VLP, unspecified
    VAC1445C: Avian influenza vaccine, mRNA
    VAC1445L: Avian influenza vaccine, mRNA
    VAC1446C: Japanese encephalitis vaccine, inactivated, whole-virus, derived from
      Vero cells, 3 micrograms
    VAC1446L: Japanese encephalitis vaccine, inactivated, whole-virus, derived from
      Vero cells, 3 micrograms
    VAC1449C: Paediatric diphtheria vaccine (toxoid, standard dose) and tetanus vaccine
      (toxoid)
    VAC1449L: DITANRIX-PEDIATRIC
    VAC1470C: COVID-19 mRNA vaccine, subvariant Omicron LP.8.1, 3 micrograms, paediatric
      dose (6 months-4 years)
    VAC1470L: COVID-19 mRNA vaccine, subvariant Omicron LP.8.1, 3 micrograms, paediatric
      dose (6 months-4 years)
    VAC1471C: COVID-19 mRNA vaccine, subvariant Omicron LP.8.1, 30 micrograms, adult
      (+ 12 years)
    VAC1471L: COVID-19 mRNA vaccine, subvariant Omicron LP.8.1, 30 micrograms, adult
      (+ 12 years)
    VAC1472C: COVID-19 mRNA vaccine, subvariant Omicron LP.8.1, 10 micrograms, paediatric
      dose (5-11 years)
    VAC1472L: COVID-19 mRNA vaccine, subvariant Omicron LP.8.1, 10 micrograms, paediatric
      dose (5-11 years)
    VAC1473C: COVID-19 mRNA vaccine, encoding a fragment of the SARS-CoV-2 spike protein,
      Omicron LP.8.1 subvariant
    VAC1473L: COVID-19 mRNA vaccine, encoding a fragment of the SARS-CoV-2 spike protein,
      Omicron LP.8.1 subvariant
    VAC1475C: Human monoclonal antibody against respiratory syncytial virus (RSV),
      clesrovimab, unspecified
    VAC1475L: Human monoclonal antibody against respiratory syncytial virus (RSV),
      clesrovimab, unspecified
    VAC1476C: Meningococcal vaccine against A, C, W, Y (conjugated polysaccharide)
      and B
    VAC1476L: Meningococcal vaccine against A, C, W, Y (conjugated polysaccharide)
      and B
  valence:
    VAL001L: Influenza valence, trivalent, live attenuated, standard dose
    VAL001S: INF-L3
    VAL002L: Typhoid valence, conjugated, Vi polysaccharide antigen linked to a carrier
      protein
    VAL002S: Ty-ViC
    VAL003L: Pertussis valence, unspecified
    VAL003S: Per
    VAL004L: Cholera valence, inactivated, whole-cell, injectable
    VAL004S: CHOL-I-I
    VAL005L: Measles valence, live attenuated
    VAL005S: MEAS-LA
    VAL006L: Brucella valence, unspecified
    VAL006S: Bruc
    VAL007L: Ebola valence, replicating vector, recombinant vesicular stomatitis virus
      (rVSV) - EBOV GP glycoprotein
    VAL007S: rVSVdG-ZEBOV-GP
    VAL008L: Pertussis  valence, acellular, standard dose
    VAL008S: aP
    VAL009L: Malaria valence, sporozoite surface protein
    VAL009S: Mala-SPO
    VAL010L: Pertussis valence, inactivated, whole-cell
    VAL010S: wP
    VAL011L: COVID-19 valence, protein subunit, recombinant spike protein (RBD)
    VAL011S: COVID-PS-rRBD
    VAL012L: Hepatitis B valence, recombinant Hepatitis B virus surface antigen (HBsAg),
      40 micrograms (dialysis patient dosage)
    VAL012S: rHBsAg-40
    VAL013L: Shingles valence, varicella zoster virus (VZV) surface glycoprotein E
      (gE)
    VAL013S: Shingles-gE
    VAL014L: Typhoid valence, unspecified
    VAL014S: Ty
    VAL015L: Influenza valence, trivalent, inactivated, split or subunit, intramuscular
      or subcutaneous route, non-adjuvanted, normal dose
    VAL015S: INF-SUnd3
    VAL016L: Rabies valence, immunoglobulin, unspecified
    VAL016S: RIG
    VAL017L: Pertussis valence, acellular, reduced dose
    VAL017S: ap
    VAL018L: Smallpox valence, third generation, minimally replicating live vaccinia
      virus
    VAL018S: POX-3G-LC16
    VAL019L: Diphtheria valence, antitoxin
    VAL019S: DATx
    VAL020L: Herpes zoster valence, live attenuated
    VAL020S: Shingles-LA
    VAL021L: Cholera valence, inactivated, whole-cell, oral
    VAL021S: CHOL-I-O
    VAL022L: Smallpox valence, live attenuated, unspecified
    VAL022S: POX-LA
    VAL023L: Influenza valence, trivalent, inactivated, split or subunit, intradermal
      route, unspecified
    VAL023S: INF-SUid3
    VAL024L: Influenza valence, trivalent, inactivated, split or subunit, unspecified
    VAL024S: INF-SU3
    VAL025L: Malaria valence, unspecified
    VAL025S: Mala
    VAL026L: Meningococcal valence B:14:P1.7,16 outer membrane vesicle proteins
    VAL026S: MenB-OMP
    VAL027L: COVID-19 valence, non-replicating adenovirus 26 vector encoding the SARS-CoV-2
      spike protein
    VAL027S: COVID-VVnr-S-Ad26
    VAL028L: Smallpox valence, third-generation, live attenuated
    VAL028S: POX-3G
    VAL029L: Influenza valence, VLP, unspecified
    VAL029S: INF-VLP
    VAL030L: Borrelia burgdorferi valence, recombinant, outer surface protein A (OspA)
    VAL030S: Lyme-OspA
    VAL031L: Tick-borne encephalitis valence, unspecified
    VAL031S: TBE
    VAL032L: Typhoid valence, unconjugated Vi polysaccharide antigen
    VAL032S: Ty-ViPS
    VAL033L: Polio type 2 valence, monovalent, live attenuated, oral
    VAL033S: mOPV2
    VAL034L: Diphtheria valence, toxoid, reduced dose
    VAL034S: d
    VAL035L: COVID-19 valence, plasmid DNA encoding the SARS-CoV-2 spike protein
    VAL035S: COVID-DNA-S
    VAL036L: Human Papillomavirus valence, VLP nonavalent, types 6, 11, 16, 18, 31,
      33, 45, 52, 58
    VAL036S: HPV-09-valent
    VAL037L: Meningococcal A valence, unconjugated polysaccharide
    VAL037S: MPV-A
    VAL038L: COVID-19 valence, replicating measles virus vector encoding the SARS-CoV-2
      spike protein
    VAL038S: COVID-VVr-S-Meas
    VAL039L: COVID-19 valence, VLP, recombinant spike protein
    VAL039S: COVID-VLP-rS
    VAL040L: Influenza valence, quadrivalent, inactivated, split or subunit, intramuscular
      or subcutaneous route, non-adjuvanted, normal dose
    VAL040S: INF-SUnd4
    VAL041L: Meningococcal A valence, polysaccharide conjugate
    VAL041S: MCV-A
    VAL042L: Polio valence, unspecified
    VAL042S: POLIO
    VAL043L: COVID-19 valence, mRNA encoding the SARS-CoV-2 spike protein, authorized
    VAL043S: COVID-mRNA-S
    VAL044L: Varicella valence, live attenuated, unspecified
    VAL044S: VZV-LA
    VAL045L: Paratyphoid fever valence, inactivated, whole-cell
    VAL045S: pTy-I
    VAL046L: Typhus valence
    VAL046S: Typhus
    VAL047L: Hepatitis B valence, immunoglobulin
    VAL047S: IgHepB
    VAL048L: Mumps valence, inactivated, whole-virus
    VAL048S: MUMPS-I
    VAL049L: Haemophilus influenzae type b valence, unconjugated PRP
    VAL049S: Hib-PS
    VAL050L: COVID-19 valence, non-replicating adenovirus 5 vector encoding the SARS-CoV-2
      spike protein, unspecified
    VAL050S: COVID-VVnr-S-Ad5
    VAL051L: Avian influenza A(H5N1) valence
    VAL051S: AH5N1
    VAL052L: Human Papillomavirus valence, VLP quadrivalent, types 6, 11, 16 and 18
    VAL052S: HPV-04-valent
    VAL053L: COVID-19 valence, protein subunit, unspecified
    VAL053S: COVID-PS
    VAL054L: COVID-19 valence, non-replicating modified Ankara vaccine vector encoding
      the SARS-CoV-2 spike protein
    VAL054S: COVID-VVnr-S-MVA
    VAL055L: Measles valence, immunoglobulin
    VAL055S: MEAS-Ig
    VAL056L: Polio valence, trivalent, inactivated, whole-virus, injectable
    VAL056S: IPV
    VAL057L: Meningococcal C valence, polysaccharide conjugate
    VAL057S: MCV-C
    VAL058L: Influenza valence, Inactivated, split or subunit, unspecified
    VAL058S: INF-SU
    VAL059L: Influenza valence, quadrivalent, live attenuated, standard dose
    VAL059S: INF-L4
    VAL060L: Chikungunya virus valence, live attenuated
    VAL060S: CHIK-LA
    VAL061L: COVID-19 valence, protein subunit, recombinant spike protein, S-2P and
      CpG1018
    VAL061S: COVID-PS-CpG1018
    VAL062L: Cholera valence, protein subunit, recombinant cholera toxin subunit B
      (rCTB)
    VAL062S: CHOL-SU-rCTB-O
    VAL063L: Botulism valence, antitoxin
    VAL063S: BAT
    VAL064L: Influenza valence, quadrivalent, inactivated, split or subunit, intramuscular
      or subcutaneous route, non-adjuvanted
    VAL064S: INF-SUNA4
    VAL065L: 'Dengue valence, live attenuated, tetravalent recombinant chimeric '
    VAL065S: RC-TDV
    VAL066L: COVID-19 valence, replicating influenza virus vector encoding the SARS-CoV-2
      spike protein
    VAL066S: COVID-VVr-S-Influ
    VAL067L: Tetanus valence, toxoid
    VAL067S: T
    VAL068L: Hepatitis B valence, unspecified
    VAL068S: HepB
    VAL069L: COVID-19 valence, non-replicating chimpanzee adenoviral vector ChAdOx1
      encoding the SARS-CoV-2 spike protein
    VAL069S: COVID-VVnr-S-ChAdOx1
    VAL070L: COVID-19 valence, non-replicating adenoviral vector encoding the SARS-CoV-2
      spike protein, unspecified
    VAL070S: COVID-VVnr-S-Ad
    VAL071L: Typhoid valence, inactivated, whole-cell
    VAL071S: Ty-I
    VAL072L: Meningococcal B valence, containing fHbp of subfamilies A and B
    VAL072S: MenB-fHbpAB
    VAL073L: COVID-19 valence, replicating viral vector, antigen presenting cells
    VAL073S: COVID-VVr+APC
    VAL074L: Influenza valence, quadrivalent, inactivated, split or subunit, high-dose
    VAL074S: INF-SUhd4
    VAL075L: Leptospira icterohaemorrhagiae valence, inactivated, whole-cell
    VAL075S: Lepto-wI
    VAL076L: COVID-19 valence, inactivated, whole-virion, unspecified
    VAL076S: COVID-IV
    VAL077L: Mumps valence, live attenuated
    VAL077S: MUMPS-LA
    VAL078L: Meningococcal Y valence, polysaccharide conjugate
    VAL078S: MCV-Y
    VAL079L: Rubella valence, live attenuated
    VAL079S: Rub-LA
    VAL080L: Rabies valence, inactivated, whole virion, unspecified
    VAL080S: Rab-I
    VAL081L: Cholera valence, unspecified
    VAL081S: CHOL
    VAL082L: Human Papillomavirus valence, types unspecified
    VAL082S: HPV
    VAL083L: Diphtheria valence, toxoid, dose unspecified
    VAL083S: D-d
    VAL084L: COVID-19 valence, replicating vesicular stomatitis virus vector encoding
      the SARS-CoV-2 spike protein
    VAL084S: COVID-VVr-S-VSV
    VAL085L: Polio type 3 valence, monovalent, live attenuated, oral
    VAL085S: mOPV3
    VAL086L: COVID-19 valence, live attenuated, unspecified
    VAL086S: COVID-LA
    VAL087L: Dengue valence, live attenuated, tetravalent chimeric recombinant based
      on the yellow fever 17D vaccine
    VAL087S: CYD-TDV
    VAL088L: Varicella valence, immunoglobulin
    VAL088S: VZV-Ig
    VAL089L: Japanese encephalitis valence, inactivated, whole-virus, unspecified
    VAL089S: JE-I
    VAL090L: Hepatitis B valence, recombinant Hepatitis B virus surface antigen (HBsAg),
      dose unspecified
    VAL090S: rHBsAg
    VAL091L: Typhoid valence, live attenuated, strain Ty21a, oral
    VAL091S: Ty-LA-O
    VAL092L: Yellow fever valence, live attenuated
    VAL092S: YF
    VAL093L: Measles valence, inactivated, whole-virus
    VAL093S: MEAS-I
    VAL094L: Influenza valence, trivalent, inactivated, fractionated or subunit, intramuscular
      or subcutaneous, non-adjuvanted, high dose
    VAL094S: INF-SUhd3
    VAL095L: COVID-19 valence, replicating Newcastle disease virus vector encoding
      the SARS-CoV-2 spike protein
    VAL095S: COVID-VVr-S-Nv
    VAL096L: BCG valence
    VAL096S: BCG
    VAL097L: Diphtheria valence, toxoid, standard dose
    VAL097S: D
    VAL098L: Meningococcal B valence, four-component
    VAL098S: 4CMenB
    VAL099L: 'Influenza valence, inactivated, pandemic influenza H1N1 2009 '
    VAL099S: INF-pdm09
    VAL100L: Japanese encephalitis valence, live attenuated virus, strain 14-14-2
    VAL100S: JE-LA-14-14-2
    VAL101L: COVID-19 valence, non-replicating Newcastle disease virus vector encoding
      the SARS-CoV-2 spike protein
    VAL101S: COVID-VVnr-S-Nv
    VAL102L: Hepatitis E valence, recombinant peptide
    VAL102S: HepE
    VAL103L: Haemophilus influenzae type b valence, PRP-conjugated, unspecified
    VAL103S: Hib-C
    VAL104L: COVID-19 valence, protein subunit, recombinant spike protein
    VAL104S: COVID-PS-rS
    VAL105L: Pneumococcal valence, unspecified
    VAL105S: Pneumo
    VAL106L: Rotavirus valence, live attenuated, unspecified
    VAL106S: ROTA-LA
    VAL107L: COVID-19 valence, protein subunit, recombinant spike protein nanoparticles
    VAL107S: COVID-PS-rSnp
    VAL108L: Ebola valence, non-replicating viral vector, Ad26.ZEBOV
    VAL108S: ZebovVRnrAd26
    VAL109L: 'Ebola valence, non-replicating viral vector, Modified Ankara vaccine '
    VAL109S: Ebola-MVA-BN-Filo
    VAL110L: Tetanus valence, immunoglobulin
    VAL110S: T-Ig
    VAL111L: Anthrax valence, acellular
    VAL111S: Bant
    VAL112L: Influenza valence, quadrivalent, inactivated, obtained from cell culture,
      split or subunit, standard dose
    VAL112S: INF-CC4
    VAL113L: Human Papillomavirus valence, VLP bivalent, types 16 and 18
    VAL113S: HPV-02-valent
    VAL114L: Hepatitis B valence, recombinant Hepatitis B virus surface antigen (HBsAg),
      10 micrograms
    VAL114S: rHBsAg-10
    VAL115L: Hepatitis B valence, recombinant Hepatitis B virus surface antigen (HBsAg),
      20 micrograms
    VAL115S: rHBsAg-20
    VAL116L: RSV valence, monoclonal antibody, palivizumab
    VAL116S: RSV-mAb-pal
    VAL117L: Pertussis valence, acellular, dose unspecified
    VAL117S: Acel
    VAL118L: Meningococcal B valence, unspecified
    VAL118S: MenB
    VAL119L: Meningococcal valence, monovalent, unconjugated polysaccharide
    VAL119S: MPV-mono
    VAL120L: Meningococcal valence, polyvalent, unconjugated polysaccharide
    VAL120S: MPV-poly
    VAL121L: Polio valence, trivalent, inactivated, whole-virus, oral
    VAL121S: IPV-O
    VAL122L: Influenza valence, trivalent, inactivated, split or subunit, intramuscular
      or subcutaneous route, non-adjuvanted
    VAL122S: INF-SUNA3
    VAL123L: Rotavirus valence, pentavalent, live attenuated virus
    VAL123S: Rota5-L
    VAL124L: Cholera valence, live attenuated, unspecified
    VAL124S: CHOL-LA
    VAL125L: Hepatitis A valence, inactivated, whole-virus, unspecified
    VAL125S: HepA-I
    VAL126L: Ebola valence, unspecified
    VAL126S: Ebola
    VAL127L: Influenza valence, quadrivalent, inactivated, split or subunit, intramuscular
      or subcutaneous route
    VAL127S: INF-SUimsc4
    VAL128L: Influenza valence, unspecified
    VAL128S: INF
    VAL129L: Herpes simplex valence, unspecified
    VAL129S: HSV
    VAL130L: Hepatitis A valence, virosome
    VAL130S: HepA-VLP
    VAL131L: Plague valence, inactivated, whole-cell
    VAL131S: Yp-I
    VAL132L: Polio type 1 valence, monovalent, live attenuated, oral
    VAL132S: mOPV1
    VAL133L: Polio valence, monovalent, live attenuated, oral, unspecified
    VAL133S: mOPV
    VAL134L: Influenza valence, quadrivalent, inactivated, split or subunit, intradermal
      route, unspecified
    VAL134S: INF-SUid4
    VAL135L: 'COVID-19 valence, mRNA encoding the SARS-CoV-2 spike protein, in clinical
      trials '
    VAL135S: COVID-mRNA-S-CT
    VAL136L: Meningococcal W valence, polysaccharide conjugate
    VAL136S: MCV-W
    VAL137L: Meningococcal C valence, unconjugated
    VAL137S: MPV-C
    VAL138L: Meningococcal W valence, unconjugated
    VAL138S: MPV-W
    VAL139L: Meningococcal Y valence, unconjugated polysaccharide
    VAL139S: MPV-Y
    VAL140L: Influenza valence, live attenuated, unspecified
    VAL140S: INF-L
    VAL141L: Rotavirus valence, live attenuated, RIX4414 monovalent
    VAL141S: ROTA-LA-mv-RIX4414
    VAL142L: Hepatitis A valence, monovalent, inactivated, whole-virus, paediatric
      dose
    VAL142S: HepA-mv-PED
    VAL143L: Hepatitis A valence, bivalent (hepatitis A and B), inactivated, whole-virus,
      paediatric dose
    VAL143S: HepA-bv-PED
    VAL144L: Hepatitis A valence, monovalent, inactivated, whole-virus, adult dose
    VAL144S: HepA-mv-ADU
    VAL145L: Hepatitis A valence, bivalent (hepatitis A and B), inactivated, whole-virus,
      adult dose
    VAL145S: HepA-bv-ADU
    VAL146L: Brucella valence, inactivated, whole-cell
    VAL146S: Bruc-I
    VAL147L: Brucella valence, protein subunit, antigen P.I. (phenol-insoluble)
    VAL147S: Bruc-IP
    VAL148L: RSV valence, immunoglobulin
    VAL148S: RSV-IG
    VAL149L: COVID-19 valence, Omicron variant, mRNA encoding the SARS-CoV-2 spike
      protein
    VAL149S: COVID-mRNA-S-OMI
    VAL150L: Dengue valence, unspecified
    VAL150S: Den
    VAL151L: Tularemia valence, unspecified
    VAL151S: Tular
    VAL152L: Influenza valence, inactivated, whole-virus, unspecified
    VAL152S: INF-I
    VAL153L: Haemophilus influenzae type b valence, PRP conjugated to diphtheria toxoid
    VAL153S: PRP-D
    VAL154L: Haemophilus influenzae type b valence, PRP conjugated to mutant diphtheria
      toxin CRM197
    VAL154S: HbOC
    VAL155L: Haemophilus influenzae type b valence, PRP conjugated to outer membrane
      protein of Neisseria meningitidis serogroup B
    VAL155S: PRP-OMP
    VAL156L: Haemophilus influenzae type b valence, PRP conjugated to tetanus toxoid
    VAL156S: PRP-T
    VAL157L: COVID-19 valence, unspecified
    VAL157S: COVID
    VAL158L: Hepatitis B valence, plasma derived
    VAL158S: pHBsAg
    VAL159L: Shingles valence, subunit
    VAL159S: Shingles-SU
    VAL160L: Shingles valence, unspecified
    VAL160S: Shingles
    VAL161L: Meningococcus B valence, multicomponent, unspecified
    VAL161S: MenB-mc
    VAL162L: COVID-19 valence, replicating virus vector, unspecified
    VAL162S: COVID-VVr
    VAL163L: COVID-19 valence, non-replicating viral vector, unspecified
    VAL163S: COVID-VVnr
    VAL164L: COVID-19 valence, non live, unspecified
    VAL164S: COVID-non-live
    VAL165L: COVID-19 valence, live, unspecified
    VAL165S: COVID-live
    VAL166L: Influenza valence, trivalent, inactivated, split or subunit, intramuscular
      or subcutaneous route, pediatric dose
    VAL166S: INF-SUped3
    VAL167L: COVID-19 valence, non-replicating viral vector, antigen presenting cells
    VAL167S: COVID-VVnr+APC
    VAL168L: COVID-19 valence, mRNA, unspecified
    VAL168S: COVID-mRNA
    VAL169L: COVID-19 valence, self-amplifying mRNA (SAM)
    VAL169S: COVID-mRNA-SAM
    VAL170L: Hepatitis B valence, recombinant Hepatitis B virus surface antigen (HBsAg),
      5 micrograms
    VAL170S: rHepB-05
    VAL171L: Venezuelan equine encephalitis valence, unspecified
    VAL171S: VEE
    VAL172L: Q fever (Coxiella burnetii) valence, unspecified
    VAL172S: Cbur
    VAL173L: Argentine hemorrhagic fever valence, Junin virus, live attenuated
    VAL173S: Junin-LA
    VAL174L: Hantavirus valence, unspecified
    VAL174S: HAN
    VAL175L: Leishmaniasis valence, unspecified
    VAL175S: Leish
    VAL176L: Human parainfluenza viruses valence, unspecified
    VAL176S: HPIVs
    VAL177L: Haemophilus influenzae type b valence, unspecified
    VAL177S: Hib
    VAL178L: COVID-19 valence, Omicron variant BA.1, mRNA encoding the SARS-CoV-2
      spike protein, 25 micrograms
    VAL178S: COVID-mRNA-S-OMI-BA.1-25
    VAL179L: Meningococcal  valence, monovalent, conjugate
    VAL179S: MCV-mono
    VAL180L: COVID-19 valence, original virus, mRNA encoding the SARS-CoV-2 spike
      protein, 100 micrograms
    VAL180S: COVID-mRNA-S-ORI-100
    VAL181L: COVID-19 valence, original virus, mRNA encoding the SARS-CoV-2 spike
      protein, 25 micrograms
    VAL181S: COVID-mRNA-S-ORI-25
    VAL182L: Measles valence, unspecified
    VAL182S: MEAS
    VAL183L: Mumps valence, unspecified
    VAL183S: MUMPS
    VAL184L: Pneumococcus valence, conjugated polysaccharide, monovalent
    VAL184S: PCV
    VAL185L: Pneumococcal valence, polysaccharide unconjugated, unspecified
    VAL185S: PPSV
    VAL186L: Pneumococcal valence, polysaccharide conjugate, serotype 1
    VAL186S: PCV-01
    VAL187L: Pneumococcal valence, polysaccharide conjugate, serotype 3
    VAL187S: PCV-03
    VAL188L: Pneumococcal valence, polysaccharide conjugate, serotype 4
    VAL188S: PCV-04
    VAL189L: Pneumococcal valence, polysaccharide conjugate, serotype 5
    VAL189S: PCV-05
    VAL190L: Pneumococcal valence, polysaccharide conjugate, serotype 6A
    VAL190S: PCV-06A
    VAL191L: Pneumococcal valence, polysaccharide conjugate, serotype 6B
    VAL191S: PCV-06B
    VAL192L: Pneumococcal valence, polysaccharide conjugate, serotype 7F
    VAL192S: PCV-07F
    VAL193L: Pneumococcal valence, polysaccharide conjugate, serotype 8
    VAL193S: PCV-08
    VAL194L: Pneumococcal valence, polysaccharide conjugate, serotype 9V
    VAL194S: PCV-09V
    VAL195L: Pneumococcal valence, polysaccharide conjugate, serotype 10A
    VAL195S: PCV-10A
    VAL196L: Pneumococcal valence, polysaccharide conjugate, serotype 11A
    VAL196S: PCV-11A
    VAL197L: Pneumococcal valence, polysaccharide conjugate, serotype 12F
    VAL197S: PCV-12F
    VAL198L: Pneumococcal valence, polysaccharide conjugate, serotype 14
    VAL198S: PCV-14
    VAL199L: Pneumococcal valence, polysaccharide conjugate, serotype 15B
    VAL199S: PCV-15B
    VAL200L: Pneumococcal valence, polysaccharide conjugate, serotype 18C
    VAL200S: PCV-18C
    VAL201L: Pneumococcal valence, polysaccharide conjugate, serotype 19A
    VAL201S: PCV-19A
    VAL202L: Pneumococcal valence, polysaccharide conjugate, serotype 19F
    VAL202S: PCV-19F
    VAL203L: Pneumococcal valence, polysaccharide conjugate, serotype 22F
    VAL203S: PCV-22F
    VAL204L: Pneumococcal valence, polysaccharide conjugate, serotype 23F
    VAL204S: PCV-23F
    VAL205L: Pneumococcal valence, polysaccharide conjugate, serotype 33F
    VAL205S: PCV-33F
    VAL206L: Pneumococcal valence, polysaccharide unconjugated, serotype 1
    VAL206S: PPSV-01
    VAL207L: Pneumococcal valence, polysaccharide unconjugated, serotype 2
    VAL207S: PPSV-02
    VAL208L: Pneumococcal valence, polysaccharide unconjugated, serotype 3
    VAL208S: PPSV-03
    VAL209L: Pneumococcal valence, polysaccharide unconjugated, serotype 4
    VAL209S: PPSV-04
    VAL210L: Pneumococcal valence, polysaccharide unconjugated, serotype 5
    VAL210S: PPSV-05
    VAL211L: Pneumococcal valence, polysaccharide unconjugated, serotype 6B
    VAL211S: PPSV-06B
    VAL212L: Pneumococcal valence, polysaccharide unconjugated, serotype 7F
    VAL212S: PPSV-07F
    VAL213L: Pneumococcal valence, polysaccharide unconjugated, serotype 8
    VAL213S: PPSV-08
    VAL214L: Pneumococcal valence, polysaccharide unconjugated, serotype 9N
    VAL214S: PPSV-09N
    VAL215L: Pneumococcal valence, polysaccharide unconjugated, serotype 9V
    VAL215S: PPSV-09V
    VAL216L: Pneumococcal valence, polysaccharide unconjugated, serotype 10A
    VAL216S: PPSV-10A
    VAL217L: Pneumococcal valence, polysaccharide unconjugated, serotype 11A
    VAL217S: PPSV-11A
    VAL218L: Pneumococcal valence, polysaccharide unconjugated, serotype 12F
    VAL218S: PPSV-12F
    VAL219L: Pneumococcal valence, polysaccharide unconjugated, serotype 14
    VAL219S: PPSV-14
    VAL220L: Pneumococcal valence, polysaccharide unconjugated, serotype 15B
    VAL220S: PPSV-15B
    VAL221L: Pneumococcal valence, polysaccharide unconjugated, serotype 15F
    VAL221S: PPSV-15F
    VAL222L: Pneumococcal valence, polysaccharide unconjugated, serotype 17F
    VAL222S: PPSV-17F
    VAL223L: Pneumococcal valence, polysaccharide unconjugated, serotype 18C
    VAL223S: PPSV-18C
    VAL224L: Pneumococcal valence, polysaccharide unconjugated, serotype 19A
    VAL224S: PPSV-19A
    VAL225L: Pneumococcal valence, polysaccharide unconjugated, serotype 19F
    VAL225S: PPSV-19F
    VAL226L: Pneumococcal valence, polysaccharide unconjugated, serotype 20
    VAL226S: PPSV-20
    VAL227L: Pneumococcal valence, polysaccharide unconjugated, serotype 22F
    VAL227S: PPSV-22F
    VAL228L: Pneumococcal valence, polysaccharide unconjugated, serotype 23F
    VAL228S: PPSV-23F
    VAL229L: Pneumococcal valence, polysaccharide unconjugated, serotype 33F
    VAL229S: PPSV-33F
    VAL230L: Influenza valence, quadrivalent, inactivated, split or subunit, unspecified
    VAL230S: INF-SU4
    VAL231L: Influenza valence, trivalent, inactivated, split or subunit, intramuscular
      or subcutaneous route
    VAL231S: INF-SUimsc3
    VAL232L: Pneumococcal valence, polysaccharide unconjugated, serotype 6A
    VAL232S: PPSV-06A
    VAL233L: Pneumococcal valence, polysaccharide unconjugated, serotype 25
    VAL233S: PPSV-25
    VAL234L: Meningococcal valence, unspecified
    VAL234S: Men
    VAL235L: Meningococcal valence, polyvalent, conjugate polysaccharide
    VAL235S: MCV-poly
    VAL236L: Human Papillomavirus valence, VLP monovalent
    VAL236S: HPV-mono
    VAL237L: Human Papillomavirus valence, VLP polyvalent
    VAL237S: HPV-poly
    VAL238L: Human Papillomavirus valence, VLP, type 6
    VAL238S: HPV-06
    VAL239L: Human Papillomavirus valence, VLP , type 11
    VAL239S: HPV-11
    VAL240L: Human Papillomavirus valence, VLP, type 16
    VAL240S: HPV-16
    VAL241L: Human Papillomavirus valence, VLP, type 18
    VAL241S: HPV-18
    VAL242L: Human Papillomavirus valence, VLP, type 31
    VAL242S: HPV-31
    VAL243L: Human Papillomavirus valence, VLP, type 33
    VAL243S: HPV-33
    VAL244L: Human Papillomavirus valence, VLP, type 58
    VAL244S: HPV-58
    VAL245L: Human Papillomavirus valence, VLP, type 52
    VAL245S: HPV-52
    VAL246L: Human Papillomavirus valence, VLP, type 45
    VAL246S: HPV-45
    VAL247L: Japanese encephalitis valence, live attenuated chimeric virus
    VAL247S: JE-LAR
    VAL248L: Japanese encephalitis valence, live attenuated virus, unspecified
    VAL248S: JE-LA
    VAL249L: Japanese encephalitis valence, unspecified
    VAL249S: JE
    VAL250L: Japanese encephalitis valence, inactivated, whole-virus, prepared on
      murine brain tissue
    VAL250S: JE-I-mb
    VAL251L: Japanese encephalitis valence, inactivated, whole-virus, derived from
      Vero cells
    VAL251S: JE-I-Vero
    VAL252L: Rabies immunoglobulin, human origin
    VAL252S: RIG-hu
    VAL253L: Rabies immunoglobulin valence, equine origin
    VAL253S: eRIG
    VAL254L: Rabies valence, inactivated, whole virion, semple type, prepared from
      goat or sheep brain tissue infected with rabies virus, contains myelin
    VAL254S: Rab-I-Semple
    VAL255L: Rabies valence, inactivated, whole virion, Fuenzalida type, prepared
      from suckling mouse brain tissue infected with rabies virus, decreased myelin
      content
    VAL255S: Rab-I-Fuenzalida
    VAL256L: Rabies valence, inactivated, whole virion, prepared from animal brain
      tissue infected with rabies virus, unspecified
    VAL256S: Rab-I-NervousTissue
    VAL257L: Rabies valence, inactivated, whole virion, cell culture-based, unspecified
    VAL257S: Rab-I-CC
    VAL258L: Rabies valence, inactivated, whole virion, cell culture-based, human
      diploid cell vaccine (HDCV) MRC-5, inactivation with ß-propiolactone
    VAL258S: Rab-I-HDCV
    VAL259L: Rabies valence, inactivated, whole virion, purified chick embryo cell
      vaccine (PCECV), obtained by growing the fixed rabies virus strain Flury LEP-25
      in primary cultures of chick fibroblasts, virus inactivated with ß-propiolactone
    VAL259S: Rab-I-PCEC
    VAL260L: Rabies valence, inactivated, whole virion, cell culture-based, purified
      Vero cell rabies vaccine (PVRV), Wistar strain, inactivation with ß-propiolactone
    VAL260S: Rab-I-PVRV
    VAL261L: Rabies valence, inactivated, whole virion, cell culture-based, primary
      hamster kidney cell vaccine (PHKCV), Beijing strain, inactivation with formalin
    VAL261S: Rab-I-PHKCV
    VAL262L: Rabies valence, inactivated, whole virion, embryonated egg-based vaccine
      (EEV), unspecified
    VAL262S: Rab-I-EEV
    VAL263L: Rabies valence, inactivated, whole virion, purified duck embryo vaccine
      (PDEV), inactivation by ß-propiolactone
    VAL263S: Rab-I-PDEV
    VAL264L: COVID-19 valence, inactivated, whole-virion, authorized
    VAL264S: COVID-IV-Auth
    VAL265L: COVID-19 valence, inactivated, whole-virion, clinical trial
    VAL265S: COVID-IV-CT
    VAL266L: Meningococcal C valence, polysaccharide tetanus toxoid conjugated
    VAL266S: MCV-C-T
    VAL267L: Meningococcal C valence, polysaccharide diphtheria toxoid conjugated
    VAL267S: MCV-C-D
    VAL268L: Meningococcal C valence, polysaccharide conjugated to CRM197 protein
    VAL268S: MCV-C-CRM
    VAL269L: Meningococcal A valence, polysaccharide conjugated to CRM197 Protein
    VAL269S: MCV-A-CRM
    VAL270L: Meningococcal A valence, polysaccharide diphtheria toxoid conjugated
    VAL270S: MCV-A-D
    VAL271L: Meningococcal A valence, polysaccharide conjugate valence to tetanus
      toxoid
    VAL271S: MCV-A-T
    VAL272L: Meningococcal W valence, polysaccharide tetanus toxoid conjugated
    VAL272S: MCV-W-T
    VAL273L: Meningococcal W valence, polysaccharide diphtheria toxoid conjugated
    VAL273S: MCV-W-D
    VAL274L: Meningococcal W valence, polysaccharide conjugated to CRM197 protein
    VAL274S: MCV-W-CRM
    VAL275L: Meningococcal Y valence, polysaccharide conjugated to CRM197 protein
    VAL275S: MCV-Y-CRM
    VAL276L: Meningococcal Y valence, polysaccharide tetanus toxoid conjugated
    VAL276S: MCV-Y-T
    VAL277L: Meningococcal Y valence, polysaccharide diphtheria toxoid conjugated
    VAL277S: MCV-Y-D
    VAL278L: Adenovirus valence, live attenuated, oral route, unspecified
    VAL278S: AD-LA
    VAL279L: Influenza valence, quadrivalent, inactivated, split or subunit, intramuscular
      or subcutaneous route, pediatric dose
    VAL279S: INF-SUped4
    VAL280L: Botulism valence, toxoid
    VAL280S: BT
    VAL281L: Adenovirus type 7 valence, live attenuated, oral route
    VAL281S: AD7-LA
    VAL282L: Adenovirus type 4 valence, live attenuated, oral route
    VAL282S: AD4-LA
    VAL283L: Hepatitis A valence, inactivated, whole-virus, paediatric dose, unspecified
    VAL283S: HepA-PED
    VAL284L: Hepatitis A valence, inactivated, whole-virus, adult dose, unspecified
    VAL284S: HepA-ADU
    VAL285L: Influenza valence, trivalent, inactivated, obtained from cell culture,
      split or subunit, standard dose
    VAL285S: INF-CC3
    VAL286L: Hepatitis A valence, live attenuated, unspecified
    VAL286S: HepA-LA
    VAL287L: Influenza valence, quadrivalent, recombinant
    VAL287S: INF-R4
    VAL288L: Hepatitis A valence, unspecified
    VAL288S: HepA
    VAL289L: COVID-19 valence, original virus, mRNA encoding the SARS-CoV-2 spike
      protein, 10 micrograms
    VAL289S: ' COVID-mRNA-S-ORI-10'
    VAL290L: COVID-19 valence, original virus, mRNA encoding the SARS-CoV-2 spike
      protein, 30 micrograms
    VAL290S: COVID-mRNA-S-ORI-30
    VAL291L: Hepatitis B valence, Recombinant, three antigens (HbS Ag, pre-S1, and
      pre-S2)
    VAL291S: HBs-r-3Ag
    VAL292L: COVID-19 valence, non-replicating adenovirus 26 vector encoding the SARS-CoV-2
      spike protein, in clinical trials
    VAL292S: COVID-VVnr-S-Ad26-CT
    VAL293L: Anthrax immunoglobulin valence
    VAL293S: Anthrax-Ig
    VAL294L: Smallpox valence, first-generation, live attenuated
    VAL294S: POX-1G
    VAL295L: Smallpox valence, second-generation, live attenuated
    VAL295S: POX-2G
    VAL296L: Smallpox valence, non-replicating, third-generation, Modified Ankara
      vaccine
    VAL296S: POX-3G-MVA
    VAL297L: Meningococcal A valence, unspecified
    VAL297S: MenA
    VAL298L: Meningococcal C valence, unspecified
    VAL298S: MenC
    VAL299L: Meningococcal Y valence, unspecified
    VAL299S: MenY
    VAL300L: Meningococcal W valence, unspecified
    VAL300S: MenW
    VAL301L: Influenza valence, trivalent, recombinant
    VAL301S: INF-R3
    VAL302L: COVID-19 valence, original virus, mRNA encoding the SARS-CoV-2 spike
      protein, 50 micrograms
    VAL302S: COVID-mRNA-S-ORI-50
    VAL303L: COVID-19 valence, original virus, mRNA encoding the SARS-CoV-2 spike
      protein
    VAL303S: COVID-mRNA-S-ORI
    VAL304L: COVID-19 valence, original virus, mRNA encoding the SARS-CoV-2 spike
      protein, 15 micrograms
    VAL304S: COVID-mRNA-S-ORI-15
    VAL305L: COVID-19 valence, Omicron variant BA.1, mRNA encoding the SARS-CoV-2
      spike protein, 15 micrograms
    VAL305S: COVID-mRNA-S-OMI-BA.1-15
    VAL306L: COVID-19 valence, original virus, mRNA encoding the SARS-CoV-2 spike
      protein, 3 micrograms
    VAL306S: COVID-mRNA-S-ORI-3
    VAL307L: COVID-19 valence, Omicron variant BA.4/5, mRNA encoding the SARS-CoV-2
      spike protein,15 micrograms
    VAL307S: COVID-mRNA-S-OMI-BA.4/5-15
    VAL308L: COVID-19 valence, Omicron variant BA.4/5, mRNA encoding the SARS-CoV-2
      spike protein, 25 micrograms
    VAL308S: COVID-mRNA-S-OMI-BA.4/5-25
    VAL309L: COVID-19 valence, Omicron variant BA.4/5, mRNA encoding the SARS-CoV-2
      spike protein, 5 micrograms
    VAL309S: COVID-mRNA-S-OMI-BA.4/5-5
    VAL310L: COVID-19 valence, original virus, mRNA encoding the SARS-CoV-2 spike
      protein, 5 micrograms
    VAL310S: COVID-mRNA-S-ORI-5
    VAL311L: Malaria valence, R21/Matrix-M pre-erythrocytic
    VAL311S: R21/Matrix-M
    VAL312L: Tick-borne encephalitis valence, inactivated, whole-virus, K23 strain
    VAL312S: TBE-K23
    VAL313L: Tick-borne encephalitis valence, inactivated, whole-virus, Neudörfl strain,
      dose not specified
    VAL313S: TBE-Neudorfl
    VAL314L: Tick-borne encephalitis valence, inactivated, whole-virus, Neudörfl strain,
      adult dose
    VAL314S: TBE-Neudorfl-ADU
    VAL315L: Tick-borne encephalitis valence, inactivated, whole-virus, Neudörfl strain,
      paediatric dose
    VAL315S: TBE-Neudorfl-PED
    VAL316L: RSV valence, protein subunit, recombinant, RSVPreF3 antigen derived from
      F protein
    VAL316S: RSV-PreF3
    VAL317L: RSV valence, antibody, unspecified
    VAL317S: RSV-Ab
    VAL318L: RSV valence, vaccine, unspecified
    VAL318S: RSV-V
    VAL319L: COVID-19 valence, non-replicating adenoviral vector encoding the SARS-CoV-2
      spike protein, inhalation vaccine, unspecified
    VAL319S: COVID-VVnr-S-INH
    VAL320L: RSV valence, monoclonal antibody, unspecified
    VAL320S: RSV-mAb
    VAL321L: RSV valence, monoclonal antibody, nirsevimab
    VAL321S: VRS-mAb-nir
    VAL322L: RSV valence, protein subunit, recombinant, glycoprotein F subtypes A
      and B
    VAL322S: RSV-PreFAB
    VAL323L: COVID-19 valence, Omicron variant XBB.1.5, mRNA encoding the SARS-CoV-2
      spike protein, 30 micrograms
    VAL323S: COVID-mRNA-S-OMI-XBB.1.5-30
    VAL324L: COVID-19 valence, Omicron variant XBB.1.5, mRNA encoding the SARS-CoV-2
      spike protein, 10 micrograms
    VAL324S: COVID-mRNA-S-OMI-XBB.1.5-10
    VAL325L: COVID-19 valence, Omicron variant XBB.1.5, mRNA encoding the SARS-CoV-2
      spike protein, 3 micrograms
    VAL325S: COVID-mRNA-S-OMI-XBB.1.5-3
    VAL326L: COVID-19 valence, Omicron BA.4/BA.5 variant, SARS-CoV-2 spike protein
      mRNA 19, 1.5 micrograms
    VAL326S: COVID-mRNA-S-OMI-BA.4/5-1.5
    VAL327L: COVID-19 valence, original virus, SARS-CoV-2 peak protein-encoding mRNA,
      1.5 micrograms
    VAL327S: COVID-mRNA-S-ORI-1.5
    VAL328L: COVID-19 valence, protein subunit, recombinant spike protein nanoparticles,
      Omicron XBB.1.5 subvariant
    VAL328S: COVID-PS-rSnp-XBB
    VAL329L: COVID-19 valence, Omicron variant XBB.1.5, mRNA encoding the SARS-CoV-2
      spike protein, 50 micrograms
    VAL329S: COVID-mRNA-S-OMI-XBB.1.5-50
    VAL330L: COVID-19 valence, Omicron variant XBB.1.5, mRNA encoding the SARS-CoV-2
      spike protein, 25 micrograms
    VAL330S: COVID-mRNA-S-OMI-XBB.1.5-25
    VAL331L: CMV valence, immunoglobulin
    VAL331S: CMV-Ig
    VAL332L: Hepatitis C valence, unspecified
    VAL332S: HepC
    VAL333L: HIV valence, unspecified
    VAL333S: HIV
    VAL334L: Melanoma valence, unspecified
    VAL334S: MEL
    VAL335L: Streptococcus pyogenes valence, unspecified
    VAL335S: SPYO
    VAL336L: Rift Valley Fever valence, unspecified
    VAL336S: RVF
    VAL337L: Smallpox valence, immunoglobulin
    VAL337S: POX-Ig
    VAL338L: RSV valence, antibody or vaccine, unspecified
    VAL338S: RSV
    VAL339L: Borrelia burgdorferi valence, unspecified
    VAL339S: Lyme
    VAL340L: Anthrax valence, unspecified
    VAL340S: Anthrax
    VAL341L: Escherichia coli valence, unspecified
    VAL341S: Eco
    VAL342L: Klebsiella pneumoniæ valence, unspecified
    VAL342S: Kpn
    VAL343L: Enterococcus faecalis valence, unspecified
    VAL343S: Efa
    VAL344L: Proteus vulgaris valence, unspecified
    VAL344S: Pvu
    VAL345L: Urinary tract infections valence, unspecified
    VAL345S: UTI
    VAL346L: Enterovirus A71 valence
    VAL346S: EV71
    VAL347L: Leptospira canicola valence, inactivated, whole-cell
    VAL347S: Lepto-ca
    VAL348L: Leptospira pomona valence, inactivated whole-cell
    VAL348S: Lepto-po
    VAL349L: Influenza valence, trivalent, inactivated, fractionated or subunit, adjuvanted
    VAL349S: INF-SUAnd3
    VAL350L: Influenza valence, quadrivalent, inactivated, fractionated or subunit,
      adjuvanted, normal dose
    VAL350S: INF-SUAnd4
    VAL351L: Influenza valence, trivalent, virosomal, unspecified
    VAL351S: INF-V3
    VAL352L: Influenza valence, quadrivalent, virosomal, unspecified
    VAL352S: INF-V4
    VAL353L: Pneumococcal valence, polysaccharide conjugate, serotype 2
    VAL353S: PCV-02
    VAL354L: Pneumococcal valence, polysaccharide conjugate, serotype 9N
    VAL354S: PCV-9N
    VAL355L: Pneumococcal valence, polysaccharide conjugate, serotype 17F
    VAL355S: PCV-17F
    VAL356L: Pneumococcal valence, polysaccharide conjugate, serotype 20
    VAL356S: PCV-20
    VAL357L: Cholera valence, live attenuated, oral
    VAL357S: CHOL-LA-O
    VAL358L: Botulism valence, immunoglobulin
    VAL358S: BIG
    VAL359L: Cholera valence, inactivated, whole-cell, unspecified
    VAL359S: CHOL-I
    VAL360L: Influenza valence, inactivated, obtained from cell culture, split or
      subunit, standard dose, unspecified
    VAL360S: INF-CC
    VAL361L: Influenza valence, recombinant, unspecified
    VAL361S: INF-R
    VAL362L: Influenza valence, virosomal, unspecified
    VAL362S: INF-V
    VAL363L: Influenza valence, trivalent, VLP, unspecified
    VAL363S: INF-VLP3
    VAL364L: Influenza valence, non-live, unspecified
    VAL364S: INF-NL
    VAL365L: Influenza valence, non-live, obtained from egg culture, unspecified
    VAL365S: INF-E
    VAL366L: Influenza valence, RNA-based, unspecified
    VAL366S: INF-RNA
    VAL367L: Cholera valence, V. cholerae O1, inactivated, whole-cell, oral
    VAL367S: CHOL-I-O1-O
    VAL368L: Cholera valence, V. cholerae O139, inactivated, whole-cell, oral
    VAL368S: CHOL-I-O139-O
    VAL369L: Pneumococcal valence, polysaccharide conjugate, serotype 15A
    VAL369S: PCV-15A
    VAL370L: Pneumococcal valence, polysaccharide conjugate, serotype 15C
    VAL370S: PCV-15C
    VAL371L: Pneumococcal valence, polysaccharide conjugate, serotype 16C
    VAL371S: PCV-16F
    VAL372L: Pneumococcal valence, polysaccharide conjugate, serotype 20A
    VAL372S: PCV-20A
    VAL373L: Pneumococcal valence, polysaccharide conjugate, serotype 23A
    VAL373S: PCV-23A
    VAL374L: Pneumococcal valence, polysaccharide conjugate, serotype 23B
    VAL374S: PCV-23B
    VAL375L: Pneumococcal valence, polysaccharide conjugate, serotype 24F
    VAL375S: PCV-24F
    VAL376L: Pneumococcal valence, polysaccharide conjugate, serotype 31
    VAL376S: PCV-31
    VAL377L: Pneumococcal valence, polysaccharide conjugate, serotype 35B
    VAL377S: PCV-35B
    VAL378L: Hepatitis B valence, recombinant Hepatitis B virus surface antigen (HBsAg),
      15 micrograms
    VAL378S: rHBsAg-15
    VAL379L: COVID-19 valence, Omicron variant JN.1, mRNA encoding the SARS-CoV-2
      spike protein, 30 micrograms
    VAL379S: COVID-mRNA-S-OMI-JN.1-30
    VAL380L: COVID-19 valence, Omicron variant JN.1, mRNA encoding the SARS-CoV-2
      spike protein, 10 micrograms
    VAL380S: COVID-mRNA-S-OMI-JN.1-10
    VAL381L: COVID-19 valence, Omicron variant JN.1, mRNA encoding the SARS-CoV-2
      spike protein, 3 micrograms
    VAL381S: COVID-mRNA-S-OMI-JN.1-3
    VAL382L: COVID-19 valence, protein subunit, recombinant spike protein in nanoparticles,
      sub-variant Omicron JN.1
    VAL382S: COVID-PS-rSnp-JN.1
    VAL383L: RSV valence, Single-stranded 5' capped mRNA encoding the RSV glycoprotein
      F stabilized in the prefusion conformation
    VAL383S: mRSV
    VAL384L: Leprosy valence, unspecified
    VAL384S: LEP
    VAL385L: Avian influenza A(H5N8) valence
    VAL385S: AH5N8
    VAL386L: Avian influenza A(H5) valence, unspecified
    VAL386S: AH5
    VAL387L: COVID-19 valence,  Omicron variant JN.1, mRNA encoding the SARS-CoV-2
      spike protein, 25 micrograms
    VAL387S: COVID-mRNA-S-OMI-JN.1-25
    VAL388L: COVID-19 valence, Omicron variant JN.1, mRNA encoding the SARS-CoV-2
      spike protein, 50 micrograms
    VAL388S: COVID-mRNA-S-OMI-JN.1-50
    VAL389L: Pseudomonas aeruginosa valence, 7 immunotypes
    VAL389S: PAER7
    VAL390L: Chikungunya virus valence, unspecified
    VAL390S: CHIK
    VAL391L: Chikungunya virus valence, VLP
    VAL391S: Chik-VLP
    VAL392L: Avian influenza valence, mRNA
    VAL392S: AH5N1-RNA
    VAL393L: COVID-19 valence, Omicron BA.1 variant, mRNA encoding the SARS-CoV-2
      spike protein
    VAL393S: COVID-mRNA-S-OMI-BA.1
    VAL394L: COVID-19 valence, Omicron variant BA.4/BA.5, mRNA encoding the SARS-CoV-2
      spike protein
    VAL394S: COVID-mRNA-S-OMI-BA.4/5
    VAL395L: COVID-19 valence, Omicron variant JN.1, mRNA encoding the SARS-CoV-2
      spike protein
    VAL395S: COVID-mRNA-S-OMI-JN.1
    VAL396L: COVID-19 valence, Omicron variant XBB.1.5, mRNA encoding the SARS-CoV-2
      spike protein
    VAL396S: COVID-mRNA-S-OMI-XBB.1.5
    VAL397L: COVID-19 valence, non-replicating viral vector encoding the peak protein
      of SARS-CoV-2, unspecified
    VAL397S: COVID-VVnr-S
    VAL398L: COVID-19 valence, replicating viral vector, virus encoding the spike
      protein of SARS-CoV-2
    VAL398S: COVID-VVr-S
    VAL399L: Typhoid valence, Vi antigen conjugated to tetanus toxoid
    VAL399S: Ty-ViC-T
    VAL400L: Typhoid valence, Vi antigen conjugated to CRM197 protein
    VAL400S: Ty-ViC-CRM
    VAL401L: Japanese encephalitis valence, inactivated, whole-virus, derived from
      Vero cells, 3 micrograms
    VAL401S: EJ-I-Vero-3
    VAL402L: Japanese encephalitis valence, inactivated, whole-virus, derived from
      Vero cells, 6 micrograms
    VAL402S: EJ-I-Vero-6
    VAL403L: Meningococcal X valence, unspecified
    VAL403S: MenX
    VAL404L: Meningococcal X valence, polysaccharide conjugate
    VAL404S: MCV-X
    VAL405L: Influenza valence, live attenuated, pandemic influenza H1N1 2009
    VAL405S: INF-pdm09-V
    VAL406L: COVID-19 valence, Omicron variant KP.2, mRNA encoding the SARS-CoV-2
      spike protein
    VAL406S: COVID-mRNA-S-OMI-KP.2
    VAL407L: COVID-19 valence, Omicron variant KP.2, mRNA encoding the SARS-CoV-2
      spike protein, 3 micrograms
    VAL407S: COVID-mRNA-S-OMI-KP.2-3
    VAL408L: COVID-19 valence, Omicron variant KP.2, mRNA encoding the SARS-CoV-2
      spike protein, 10 micrograms
    VAL408S: COVID-mRNA-S-OMI-KP.2-10
    VAL409L: COVID-19 valence, Omicron variant KP.2, mRNA encoding the SARS-CoV-2
      spike protein, 30 micrograms
    VAL409S: COVID-mRNA-S-OMI-KP.2-30
    VAL410L: COVID-19 valence, protein subunit, recombinant N protein
    VAL410S: COVID-PS-rN
    VAL411L: COVID-19 valence, Omicron variant BA.4/5, mRNA encoding the SARS-CoV-2
      spike protein, 50 micrograms
    VAL411S: COVID-mRNA-S-OMI-BA.4/5-50
    VAL412L: COVID-19 valence, Omicron variant BA.1, mRNA encoding the SARS-CoV-2
      spike protein, 50 micrograms
    VAL412S: COVID-mRNA-S-OMI-BA.1-50
    VAL413L: COVID-19 valence, protein subunit, recombinant spike protein (RBD), Omicron
      XBB.1.16 subvariant
    VAL413S: COVID-PS-rRBD-XBB.1.16
    VAL414L: Diphtheria valence, unspecified
    VAL414S: DIPH
    VAL415L: Anthrax valence, acellular, adjuvanted
    VAL415S: BantAdj
    VAL416L: COVID-19 valence, protein subunit, recombinant spike protein, adjuvanted
    VAL416S: COVID-PS-rS-A
    VAL417L: COVID-19 valence, Omicron BA.2 variant, mRNA encoding the SARS-CoV-2
      spike protein
    VAL417S: COVID-mRNA-S-OMI-BA.2
    VAL418L: Smallpox valence, active or passive immunization products
    VAL418S: POX
    VAL419L: Botulism valence, active or passive immunization products
    VAL419S: BOT
    VAL420L: Botulism valence, passive immunization products
    VAL420S: BOT-passive
    VAL421L: Argentine hemorrhagic fever valence, Junin virus, unspecified
    VAL421S: Junin
    VAL422L: Plague valence, unspecified
    VAL422S: Yp
    VAL423L: COVID-19 valence, Omicron variant LP.8.1, mRNA encoding the SARS-CoV-2
      spike protein
    VAL423S: Covid-ARNm-S-OMI-LP.8.1
    VAL424L: COVID-19 valence, Omicron variant LP.8.1, mRNA encoding the SARS-CoV-2
      spike protein, 30 micrograms
    VAL424S: Covid-ARNm-S-OMI-LP.8.1-30
    VAL425L: COVID-19 valence, Omicron variant LP.8.1, mRNA encoding the SARS-CoV-2
      spike protein, 10 micrograms
    VAL425S: Covid-ARNm-S-OMI-LP.8.1-10
    VAL426L: COVID-19 valence, Omicron variant LP.8.1, mRNA encoding the SARS-CoV-2
      spike protein, 3 micrograms
    VAL426S: Covid-ARNm-S-OMI-LP.8.1-3
    VAL427L: COVID-19 valence, mRNA encoding a fragment of the SARS-CoV-2 spike protein
    VAL427S: Covid-ARNm-S-frag
    VAL428L: Valence COVID-19, mRNA encoding the NTD and RBD fragments of the spike
      protein, Omicron LP.8.1 variant
    VAL428S: Covid-ARNm-S-frag-OMI-LP.8.1
    VAL429L: RSV valence, monoclonal antibody, clesrovimab
    VAL429S: VRS-mAb-cle
    VAL430L: Tick-borne encephalitis valence, inactivated, whole-virus, K23 strain,
      0,25 mL
    VAL430S: TBE-K23-25
    VAL431L: Tick-borne encephalitis valence, inactivated, whole-virus, K23 strain,
      0,50 mL
    VAL431S: TBE-K23-50
